After-Hours Stock Movers: Acasti Pharma,Calamp,BlackBerry and more_老虎社区_美港股上老虎

After-Hours Stock Movers: Acasti Pharma,Calamp,BlackBerry and more

StreetInsider2021-12-22

After-Hours Stock Movers:

Acasti Pharma (NASDAQ:ACST)+30%; Oppenheimer initiates coverage on Acasti Pharma (NASDAQ:ACST) with a Outperform rating and a price target of $6.00.

Voya Financial (NYSE:VOYA)+8%; will replace CoreSite Realty Corp. (NYSE:COR) in theS&PMidCap 400 effective prior to the opening of trading on Tuesday, December 28. S&P 500 / 100 constituent American Tower Corp. (NYSE:AMT) is acquiring CoreSite Realty in a deal expected to be completed soon pending final closing conditions.

Repro Med Systems (NASDAQ:KRMD)+10%; today announcedFDA510(k) clearance that expands on-label use of the FREEDOM60 Infusion System to two additional subcutaneous Ig (SCIg) medications, Cutaquig®, manufactured by Octapharma, and Xembify®, manufactured by Grifols.

Calamp Corp. (NASDAQ:CAMP)-14.9%; reported Q3 EPS of ($0.08), $0.16 worse than the analyst estimate of $0.08. Revenue for the quarter came in at $69 million versus the consensus estimate of $79.18 million.

BlackBerry (NYSE:BB) -1.6%;reported Q3 EPS $0.00 vs $(0.07) Estimate,Sales $184.00M Beat $177.25M Estimate.

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

224

SanWangtikup
·2021-12-22
Like pls
回复
1
举报
Bspn
·2021-12-22
Ok
回复
点赞
举报
onglaihuat
·2021-12-22
G
回复
1
举报
Helloyah
·2021-12-22
to monitor
回复
1
举报
收起
- onglaihuat:
  g
  2021-12-22
  回复
  举报
Jialatsia
·2021-12-22
Meep
回复
2
举报
Phyusin
·2021-12-22
Wow
回复
3
举报
Hayleyxn
·2021-12-22
Oo
回复
2
举报
收起
- Hayleyxn:
  ok
  2021-12-22
  回复
  举报
Gackky
·2021-12-22
blackberry wow.. after years of lying low[Sly]
回复
4
举报
收起
- Venus_M:
  only move a little bit
  2021-12-22
  回复
  举报
- Helloyah:
  agree
  2021-12-22
  回复
  举报
- JohnL:
  Yes
  2021-12-22
  回复
  举报
CherryPang
·2021-12-22
Good
回复
5
举报
Juanlee
·2021-12-22
Blackberry germinating
回复
6
举报
Ssimsim
·2021-12-22
Good
回复
4
举报
Leekeez
·2021-12-22
Ok
回复
2
举报
Troytan
·2021-12-22
BB back to life
回复
2
举报
Jess261
·2021-12-22
Okay
回复
2
举报
BCbcbc
·2021-12-22
Nice
回复
2
举报
kksuen
·2021-12-22
Like pls
回复
3
举报
收起
- kaite:
  ok
  2021-12-22
  回复
  举报
- Zenkyn:
  ok
  2021-12-22
  回复
  举报
Zenkyn
·2021-12-22
Ok
回复
2
举报
收起
- kksuen:
  ok
  2021-12-22
  回复
  举报
justforcoins
·2021-12-22
K
回复
3
举报
10f6ccb4
·2021-12-22
[smile]
回复
3
举报
收起
- justforcoins:
  k
  2021-12-22
  回复
  举报
hyhop
·2021-12-22
Ok
回复
4
举报
收起
- 10f6ccb4:
  [smile]
  2021-12-22
  回复
  举报
- hyhop:
  ok
  2021-12-22
  回复
  举报

热议股票

7x24

全部

{"i18n":{"language":"zh_CN"},"data":{"share":"https://ttm.financial/m/news/1111567016?lang=zh_CN&edition=full","thumbnail":"","is_english":true,"pubTime":"2021-12-22 08:35","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1111567016","market":"us","top_or_hot":-1,"title":"After-Hours Stock Movers: Acasti Pharma,Calamp,BlackBerry and more","media":"StreetInsider","content":"<p>After-Hours Stock Movers:</p>\n<p>Acasti Pharma (NASDAQ:ACST)<b>+30%</b>; Oppenheimer initiates coverage on Acasti Pharma (NASDAQ:ACST) with a Outperform rating and a price target of $6.00.</p>\n<p>Voya Financial (NYSE:VOYA)<b>+8%</b>; will replace CoreSite Realty Corp. (NYSE:COR) in theS&amp;PMidCap 400 effective prior to the opening of trading on Tuesday, December 28. S&amp;P 500 / 100 constituent American Tower Corp. (NYSE:AMT) is acquiring CoreSite Realty in a deal expected to be completed soon pending final closing conditions.</p>\n<p>Repro Med Systems (NASDAQ:KRMD)<b>+10%</b>; today announcedFDA510(k) clearance that expands on-label use of the FREEDOM60 Infusion System to two additional subcutaneous Ig (SCIg) medications, Cutaquig®, manufactured by Octapharma, and Xembify®, manufactured by Grifols.</p>\n<p>Calamp Corp. (NASDAQ:CAMP)<b>-14.9%</b>; reported Q3 EPS of ($0.08), $0.16 worse than the analyst estimate of $0.08. Revenue for the quarter came in at $69 million versus the consensus estimate of $79.18 million.</p>\n<p>BlackBerry&nbsp;(NYSE:BB)&nbsp;-1.6%;reported&nbsp;Q3 EPS $0.00 vs $(0.07) Estimate,Sales $184.00M Beat $177.25M Estimate.</p>","source":"highlight_streetinsider","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>After-Hours Stock Movers: Acasti Pharma,Calamp,BlackBerry and more</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAfter-Hours Stock Movers: Acasti Pharma,Calamp,BlackBerry and more\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-22 08:35 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.streetinsider.com/Special+Reports/After-Hours+Stock+Movers+1221%3A+%28ACST%29+%28VOYA%29+%28KRMD%29+Higher%2C+%28CAMP%29+Lower/19381258.html><strong>StreetInsider</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>After-Hours Stock Movers:\nAcasti Pharma (NASDAQ:ACST)+30%; Oppenheimer initiates coverage on Acasti Pharma (NASDAQ:ACST) with a Outperform rating and a price target of $6.00.\nVoya Financial (NYSE:VOYA...</p>\n\n<a href=\"https://www.streetinsider.com/Special+Reports/After-Hours+Stock+Movers+1221%3A+%28ACST%29+%28VOYA%29+%28KRMD%29+Higher%2C+%28CAMP%29+Lower/19381258.html\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"VOYA","symbol_name":"Voya Financial, Inc.","start_time":0,"source_url":"https://www.streetinsider.com/Special+Reports/After-Hours+Stock+Movers+1221%3A+%28ACST%29+%28VOYA%29+%28KRMD%29+Higher%2C+%28CAMP%29+Lower/19381258.html","article_id":"1111567016","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1111567016","pubTimestamp":1640133346,"columns":[],"sourceInfo":{"source_id":"highlight_streetinsider","name":"StreetInsider"},"weMediaInfo":null,"summary":"After-Hours Stock Movers:\nAcasti Pharma (NASDAQ:ACST)+30%; Oppenheimer initiates coverage on Acasti ","collect":0,"end_time":0,"defaultTopTitle":"streetinsider.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"VOYA":"Voya Financial, Inc.","BB":"黑莓","CAMP":"Camp4 Therapeutics Corp.","KRMD":"Repro Med Systems, Inc."},"translate_title":"盘后股票搬运工：Acasti Pharma、Calamp、黑莓等","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ACST":0.9,"BB":0.9,"CAMP":0.9,"KRMD":0.9,"VOYA":0.9},"content_text":"After-Hours Stock Movers:\nAcasti Pharma (NASDAQ:ACST)+30%; Oppenheimer initiates coverage on Acasti Pharma (NASDAQ:ACST) with a Outperform rating and a price target of $6.00.\nVoya Financial (NYSE:VOYA)+8%; will replace CoreSite Realty Corp. (NYSE:COR) in theS&PMidCap 400 effective prior to the opening of trading on Tuesday, December 28. S&P 500 / 100 constituent American Tower Corp. (NYSE:AMT) is acquiring CoreSite Realty in a deal expected to be completed soon pending final closing conditions.\nRepro Med Systems (NASDAQ:KRMD)+10%; today announcedFDA510(k) clearance that expands on-label use of the FREEDOM60 Infusion System to two additional subcutaneous Ig (SCIg) medications, Cutaquig®, manufactured by Octapharma, and Xembify®, manufactured by Grifols.\nCalamp Corp. (NASDAQ:CAMP)-14.9%; reported Q3 EPS of ($0.08), $0.16 worse than the analyst estimate of $0.08. Revenue for the quarter came in at $69 million versus the consensus estimate of $79.18 million.\nBlackBerry (NYSE:BB) -1.6%;reported Q3 EPS $0.00 vs $(0.07) Estimate,Sales $184.00M Beat $177.25M Estimate.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"code":"91000000","status":"200"},"commentList":[{"id":691185827,"gmtCreate":1640149949264,"gmtModify":1640149950003,"author":{"id":"4087452914358580","authorId":"4087452914358580","name":"SanWangtikup","avatar":"https://static.tigerbbs.com/c7f061d50a9f915d0ce8e8c879871960","vip":1,"crmLevel":2,"crmLevelSwitch":0,"authorIdStr":"4087452914358580","idStr":"4087452914358580"},"htmlText":"Like pls&nbsp;","listText":"Like pls&nbsp;","text":"Like pls","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/691185827","repostId":1111567016,"repostType":4,"repost":{"id":"1111567016","kind":"news","pubTimestamp":1640133346,"share":"https://ttm.financial/m/news/1111567016?lang=&edition=full","pubTime":"2021-12-22 08:35","market":"us","language":"en","title":"After-Hours Stock Movers: Acasti Pharma,Calamp,BlackBerry and more","url":"https://stock-news.laohu8.com/highlight/detail?id=1111567016","media":"StreetInsider","summary":"After-Hours Stock Movers:\nAcasti Pharma (NASDAQ:ACST)+30%; Oppenheimer initiates coverage on Acasti ","content":"<p>After-Hours Stock Movers:</p>\n<p>Acasti Pharma (NASDAQ:ACST)<b>+30%</b>; Oppenheimer initiates coverage on Acasti Pharma (NASDAQ:ACST) with a Outperform rating and a price target of $6.00.</p>\n<p>Voya Financial (NYSE:VOYA)<b>+8%</b>; will replace CoreSite Realty Corp. (NYSE:COR) in theS&amp;PMidCap 400 effective prior to the opening of trading on Tuesday, December 28. S&amp;P 500 / 100 constituent American Tower Corp. (NYSE:AMT) is acquiring CoreSite Realty in a deal expected to be completed soon pending final closing conditions.</p>\n<p>Repro Med Systems (NASDAQ:KRMD)<b>+10%</b>; today announcedFDA510(k) clearance that expands on-label use of the FREEDOM60 Infusion System to two additional subcutaneous Ig (SCIg) medications, Cutaquig®, manufactured by Octapharma, and Xembify®, manufactured by Grifols.</p>\n<p>Calamp Corp. (NASDAQ:CAMP)<b>-14.9%</b>; reported Q3 EPS of ($0.08), $0.16 worse than the analyst estimate of $0.08. Revenue for the quarter came in at $69 million versus the consensus estimate of $79.18 million.</p>\n<p>BlackBerry&nbsp;(NYSE:BB)&nbsp;-1.6%;reported&nbsp;Q3 EPS $0.00 vs $(0.07) Estimate,Sales $184.00M Beat $177.25M Estimate.</p>","source":"highlight_streetinsider","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>After-Hours Stock Movers: Acasti Pharma,Calamp,BlackBerry and more</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAfter-Hours Stock Movers: Acasti Pharma,Calamp,BlackBerry and more\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-22 08:35 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.streetinsider.com/Special+Reports/After-Hours+Stock+Movers+1221%3A+%28ACST%29+%28VOYA%29+%28KRMD%29+Higher%2C+%28CAMP%29+Lower/19381258.html><strong>StreetInsider</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>After-Hours Stock Movers:\nAcasti Pharma (NASDAQ:ACST)+30%; Oppenheimer initiates coverage on Acasti Pharma (NASDAQ:ACST) with a Outperform rating and a price target of $6.00.\nVoya Financial (NYSE:VOYA...</p>\n\n<a href=\"https://www.streetinsider.com/Special+Reports/After-Hours+Stock+Movers+1221%3A+%28ACST%29+%28VOYA%29+%28KRMD%29+Higher%2C+%28CAMP%29+Lower/19381258.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"VOYA":"Voya Financial, Inc.","BB":"黑莓","CAMP":"Camp4 Therapeutics Corp.","KRMD":"Repro Med Systems, Inc."},"source_url":"https://www.streetinsider.com/Special+Reports/After-Hours+Stock+Movers+1221%3A+%28ACST%29+%28VOYA%29+%28KRMD%29+Higher%2C+%28CAMP%29+Lower/19381258.html","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1111567016","content_text":"After-Hours Stock Movers:\nAcasti Pharma (NASDAQ:ACST)+30%; Oppenheimer initiates coverage on Acasti Pharma (NASDAQ:ACST) with a Outperform rating and a price target of $6.00.\nVoya Financial (NYSE:VOYA)+8%; will replace CoreSite Realty Corp. (NYSE:COR) in theS&PMidCap 400 effective prior to the opening of trading on Tuesday, December 28. S&P 500 / 100 constituent American Tower Corp. (NYSE:AMT) is acquiring CoreSite Realty in a deal expected to be completed soon pending final closing conditions.\nRepro Med Systems (NASDAQ:KRMD)+10%; today announcedFDA510(k) clearance that expands on-label use of the FREEDOM60 Infusion System to two additional subcutaneous Ig (SCIg) medications, Cutaquig®, manufactured by Octapharma, and Xembify®, manufactured by Grifols.\nCalamp Corp. (NASDAQ:CAMP)-14.9%; reported Q3 EPS of ($0.08), $0.16 worse than the analyst estimate of $0.08. Revenue for the quarter came in at $69 million versus the consensus estimate of $79.18 million.\nBlackBerry (NYSE:BB) -1.6%;reported Q3 EPS $0.00 vs $(0.07) Estimate,Sales $184.00M Beat $177.25M Estimate.","news_type":1,"symbols_score_info":{"ACST":0.9,"BB":0.9,"CAMP":0.9,"KRMD":0.9,"VOYA":0.9}},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"},{"id":691349014,"gmtCreate":1640141033530,"gmtModify":1640141033686,"author":{"id":"3582502134655895","authorId":"3582502134655895","name":"Bspn","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":4,"crmLevelSwitch":0,"authorIdStr":"3582502134655895","idStr":"3582502134655895"},"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/691349014","repostId":1111567016,"repostType":2,"repost":{"id":"1111567016","kind":"news","pubTimestamp":1640133346,"share":"https://ttm.financial/m/news/1111567016?lang=&edition=full","pubTime":"2021-12-22 08:35","market":"us","language":"en","title":"After-Hours Stock Movers: Acasti Pharma,Calamp,BlackBerry and more","url":"https://stock-news.laohu8.com/highlight/detail?id=1111567016","media":"StreetInsider","summary":"After-Hours Stock Movers:\nAcasti Pharma (NASDAQ:ACST)+30%; Oppenheimer initiates coverage on Acasti ","content":"<p>After-Hours Stock Movers:</p>\n<p>Acasti Pharma (NASDAQ:ACST)<b>+30%</b>; Oppenheimer initiates coverage on Acasti Pharma (NASDAQ:ACST) with a Outperform rating and a price target of $6.00.</p>\n<p>Voya Financial (NYSE:VOYA)<b>+8%</b>; will replace CoreSite Realty Corp. (NYSE:COR) in theS&amp;PMidCap 400 effective prior to the opening of trading on Tuesday, December 28. S&amp;P 500 / 100 constituent American Tower Corp. (NYSE:AMT) is acquiring CoreSite Realty in a deal expected to be completed soon pending final closing conditions.</p>\n<p>Repro Med Systems (NASDAQ:KRMD)<b>+10%</b>; today announcedFDA510(k) clearance that expands on-label use of the FREEDOM60 Infusion System to two additional subcutaneous Ig (SCIg) medications, Cutaquig®, manufactured by Octapharma, and Xembify®, manufactured by Grifols.</p>\n<p>Calamp Corp. (NASDAQ:CAMP)<b>-14.9%</b>; reported Q3 EPS of ($0.08), $0.16 worse than the analyst estimate of $0.08. Revenue for the quarter came in at $69 million versus the consensus estimate of $79.18 million.</p>\n<p>BlackBerry&nbsp;(NYSE:BB)&nbsp;-1.6%;reported&nbsp;Q3 EPS $0.00 vs $(0.07) Estimate,Sales $184.00M Beat $177.25M Estimate.</p>","source":"highlight_streetinsider","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>After-Hours Stock Movers: Acasti Pharma,Calamp,BlackBerry and more</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAfter-Hours Stock Movers: Acasti Pharma,Calamp,BlackBerry and more\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-22 08:35 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.streetinsider.com/Special+Reports/After-Hours+Stock+Movers+1221%3A+%28ACST%29+%28VOYA%29+%28KRMD%29+Higher%2C+%28CAMP%29+Lower/19381258.html><strong>StreetInsider</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>After-Hours Stock Movers:\nAcasti Pharma (NASDAQ:ACST)+30%; Oppenheimer initiates coverage on Acasti Pharma (NASDAQ:ACST) with a Outperform rating and a price target of $6.00.\nVoya Financial (NYSE:VOYA...</p>\n\n<a href=\"https://www.streetinsider.com/Special+Reports/After-Hours+Stock+Movers+1221%3A+%28ACST%29+%28VOYA%29+%28KRMD%29+Higher%2C+%28CAMP%29+Lower/19381258.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"VOYA":"Voya Financial, Inc.","BB":"黑莓","CAMP":"Camp4 Therapeutics Corp.","KRMD":"Repro Med Systems, Inc."},"source_url":"https://www.streetinsider.com/Special+Reports/After-Hours+Stock+Movers+1221%3A+%28ACST%29+%28VOYA%29+%28KRMD%29+Higher%2C+%28CAMP%29+Lower/19381258.html","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1111567016","content_text":"After-Hours Stock Movers:\nAcasti Pharma (NASDAQ:ACST)+30%; Oppenheimer initiates coverage on Acasti Pharma (NASDAQ:ACST) with a Outperform rating and a price target of $6.00.\nVoya Financial (NYSE:VOYA)+8%; will replace CoreSite Realty Corp. (NYSE:COR) in theS&PMidCap 400 effective prior to the opening of trading on Tuesday, December 28. S&P 500 / 100 constituent American Tower Corp. (NYSE:AMT) is acquiring CoreSite Realty in a deal expected to be completed soon pending final closing conditions.\nRepro Med Systems (NASDAQ:KRMD)+10%; today announcedFDA510(k) clearance that expands on-label use of the FREEDOM60 Infusion System to two additional subcutaneous Ig (SCIg) medications, Cutaquig®, manufactured by Octapharma, and Xembify®, manufactured by Grifols.\nCalamp Corp. (NASDAQ:CAMP)-14.9%; reported Q3 EPS of ($0.08), $0.16 worse than the analyst estimate of $0.08. Revenue for the quarter came in at $69 million versus the consensus estimate of $79.18 million.\nBlackBerry (NYSE:BB) -1.6%;reported Q3 EPS $0.00 vs $(0.07) Estimate,Sales $184.00M Beat $177.25M Estimate.","news_type":1,"symbols_score_info":{"ACST":0.9,"BB":0.9,"CAMP":0.9,"KRMD":0.9,"VOYA":0.9}},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"},{"id":691356002,"gmtCreate":1640140503697,"gmtModify":1640140503960,"author":{"id":"3585648549833646","authorId":"3585648549833646","name":"onglaihuat","avatar":"https://static.tigerbbs.com/8beed4d730329353a71b58a536060ca8","vip":1,"crmLevel":2,"crmLevelSwitch":0,"authorIdStr":"3585648549833646","idStr":"3585648549833646"},"htmlText":"G","listText":"G","text":"G","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/691356002","repostId":1111567016,"repostType":4,"repost":{"id":"1111567016","kind":"news","pubTimestamp":1640133346,"share":"https://ttm.financial/m/news/1111567016?lang=&edition=full","pubTime":"2021-12-22 08:35","market":"us","language":"en","title":"After-Hours Stock Movers: Acasti Pharma,Calamp,BlackBerry and more","url":"https://stock-news.laohu8.com/highlight/detail?id=1111567016","media":"StreetInsider","summary":"After-Hours Stock Movers:\nAcasti Pharma (NASDAQ:ACST)+30%; Oppenheimer initiates coverage on Acasti ","content":"<p>After-Hours Stock Movers:</p>\n<p>Acasti Pharma (NASDAQ:ACST)<b>+30%</b>; Oppenheimer initiates coverage on Acasti Pharma (NASDAQ:ACST) with a Outperform rating and a price target of $6.00.</p>\n<p>Voya Financial (NYSE:VOYA)<b>+8%</b>; will replace CoreSite Realty Corp. (NYSE:COR) in theS&amp;PMidCap 400 effective prior to the opening of trading on Tuesday, December 28. S&amp;P 500 / 100 constituent American Tower Corp. (NYSE:AMT) is acquiring CoreSite Realty in a deal expected to be completed soon pending final closing conditions.</p>\n<p>Repro Med Systems (NASDAQ:KRMD)<b>+10%</b>; today announcedFDA510(k) clearance that expands on-label use of the FREEDOM60 Infusion System to two additional subcutaneous Ig (SCIg) medications, Cutaquig®, manufactured by Octapharma, and Xembify®, manufactured by Grifols.</p>\n<p>Calamp Corp. (NASDAQ:CAMP)<b>-14.9%</b>; reported Q3 EPS of ($0.08), $0.16 worse than the analyst estimate of $0.08. Revenue for the quarter came in at $69 million versus the consensus estimate of $79.18 million.</p>\n<p>BlackBerry&nbsp;(NYSE:BB)&nbsp;-1.6%;reported&nbsp;Q3 EPS $0.00 vs $(0.07) Estimate,Sales $184.00M Beat $177.25M Estimate.</p>","source":"highlight_streetinsider","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>After-Hours Stock Movers: Acasti Pharma,Calamp,BlackBerry and more</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAfter-Hours Stock Movers: Acasti Pharma,Calamp,BlackBerry and more\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-22 08:35 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.streetinsider.com/Special+Reports/After-Hours+Stock+Movers+1221%3A+%28ACST%29+%28VOYA%29+%28KRMD%29+Higher%2C+%28CAMP%29+Lower/19381258.html><strong>StreetInsider</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>After-Hours Stock Movers:\nAcasti Pharma (NASDAQ:ACST)+30%; Oppenheimer initiates coverage on Acasti Pharma (NASDAQ:ACST) with a Outperform rating and a price target of $6.00.\nVoya Financial (NYSE:VOYA...</p>\n\n<a href=\"https://www.streetinsider.com/Special+Reports/After-Hours+Stock+Movers+1221%3A+%28ACST%29+%28VOYA%29+%28KRMD%29+Higher%2C+%28CAMP%29+Lower/19381258.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"VOYA":"Voya Financial, Inc.","BB":"黑莓","CAMP":"Camp4 Therapeutics Corp.","KRMD":"Repro Med Systems, Inc."},"source_url":"https://www.streetinsider.com/Special+Reports/After-Hours+Stock+Movers+1221%3A+%28ACST%29+%28VOYA%29+%28KRMD%29+Higher%2C+%28CAMP%29+Lower/19381258.html","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1111567016","content_text":"After-Hours Stock Movers:\nAcasti Pharma (NASDAQ:ACST)+30%; Oppenheimer initiates coverage on Acasti Pharma (NASDAQ:ACST) with a Outperform rating and a price target of $6.00.\nVoya Financial (NYSE:VOYA)+8%; will replace CoreSite Realty Corp. (NYSE:COR) in theS&PMidCap 400 effective prior to the opening of trading on Tuesday, December 28. S&P 500 / 100 constituent American Tower Corp. (NYSE:AMT) is acquiring CoreSite Realty in a deal expected to be completed soon pending final closing conditions.\nRepro Med Systems (NASDAQ:KRMD)+10%; today announcedFDA510(k) clearance that expands on-label use of the FREEDOM60 Infusion System to two additional subcutaneous Ig (SCIg) medications, Cutaquig®, manufactured by Octapharma, and Xembify®, manufactured by Grifols.\nCalamp Corp. (NASDAQ:CAMP)-14.9%; reported Q3 EPS of ($0.08), $0.16 worse than the analyst estimate of $0.08. Revenue for the quarter came in at $69 million versus the consensus estimate of $79.18 million.\nBlackBerry (NYSE:BB) -1.6%;reported Q3 EPS $0.00 vs $(0.07) Estimate,Sales $184.00M Beat $177.25M Estimate.","news_type":1,"symbols_score_info":{"ACST":0.9,"BB":0.9,"CAMP":0.9,"KRMD":0.9,"VOYA":0.9}},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"},{"id":691327054,"gmtCreate":1640139933083,"gmtModify":1640139933399,"author":{"id":"4099650032870960","authorId":"4099650032870960","name":"Helloyah","avatar":"https://static.tigerbbs.com/04a600ad88159fff17f3cf715916ac3a","vip":1,"crmLevel":2,"crmLevelSwitch":0,"authorIdStr":"4099650032870960","idStr":"4099650032870960"},"htmlText":"to monitor","listText":"to monitor","text":"to monitor","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/691327054","repostId":1111567016,"repostType":4,"repost":{"id":"1111567016","kind":"news","pubTimestamp":1640133346,"share":"https://ttm.financial/m/news/1111567016?lang=&edition=full","pubTime":"2021-12-22 08:35","market":"us","language":"en","title":"After-Hours Stock Movers: Acasti Pharma,Calamp,BlackBerry and more","url":"https://stock-news.laohu8.com/highlight/detail?id=1111567016","media":"StreetInsider","summary":"After-Hours Stock Movers:\nAcasti Pharma (NASDAQ:ACST)+30%; Oppenheimer initiates coverage on Acasti ","content":"<p>After-Hours Stock Movers:</p>\n<p>Acasti Pharma (NASDAQ:ACST)<b>+30%</b>; Oppenheimer initiates coverage on Acasti Pharma (NASDAQ:ACST) with a Outperform rating and a price target of $6.00.</p>\n<p>Voya Financial (NYSE:VOYA)<b>+8%</b>; will replace CoreSite Realty Corp. (NYSE:COR) in theS&amp;PMidCap 400 effective prior to the opening of trading on Tuesday, December 28. S&amp;P 500 / 100 constituent American Tower Corp. (NYSE:AMT) is acquiring CoreSite Realty in a deal expected to be completed soon pending final closing conditions.</p>\n<p>Repro Med Systems (NASDAQ:KRMD)<b>+10%</b>; today announcedFDA510(k) clearance that expands on-label use of the FREEDOM60 Infusion System to two additional subcutaneous Ig (SCIg) medications, Cutaquig®, manufactured by Octapharma, and Xembify®, manufactured by Grifols.</p>\n<p>Calamp Corp. (NASDAQ:CAMP)<b>-14.9%</b>; reported Q3 EPS of ($0.08), $0.16 worse than the analyst estimate of $0.08. Revenue for the quarter came in at $69 million versus the consensus estimate of $79.18 million.</p>\n<p>BlackBerry&nbsp;(NYSE:BB)&nbsp;-1.6%;reported&nbsp;Q3 EPS $0.00 vs $(0.07) Estimate,Sales $184.00M Beat $177.25M Estimate.</p>","source":"highlight_streetinsider","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>After-Hours Stock Movers: Acasti Pharma,Calamp,BlackBerry and more</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAfter-Hours Stock Movers: Acasti Pharma,Calamp,BlackBerry and more\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-22 08:35 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.streetinsider.com/Special+Reports/After-Hours+Stock+Movers+1221%3A+%28ACST%29+%28VOYA%29+%28KRMD%29+Higher%2C+%28CAMP%29+Lower/19381258.html><strong>StreetInsider</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>After-Hours Stock Movers:\nAcasti Pharma (NASDAQ:ACST)+30%; Oppenheimer initiates coverage on Acasti Pharma (NASDAQ:ACST) with a Outperform rating and a price target of $6.00.\nVoya Financial (NYSE:VOYA...</p>\n\n<a href=\"https://www.streetinsider.com/Special+Reports/After-Hours+Stock+Movers+1221%3A+%28ACST%29+%28VOYA%29+%28KRMD%29+Higher%2C+%28CAMP%29+Lower/19381258.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"VOYA":"Voya Financial, Inc.","BB":"黑莓","CAMP":"Camp4 Therapeutics Corp.","KRMD":"Repro Med Systems, Inc."},"source_url":"https://www.streetinsider.com/Special+Reports/After-Hours+Stock+Movers+1221%3A+%28ACST%29+%28VOYA%29+%28KRMD%29+Higher%2C+%28CAMP%29+Lower/19381258.html","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1111567016","content_text":"After-Hours Stock Movers:\nAcasti Pharma (NASDAQ:ACST)+30%; Oppenheimer initiates coverage on Acasti Pharma (NASDAQ:ACST) with a Outperform rating and a price target of $6.00.\nVoya Financial (NYSE:VOYA)+8%; will replace CoreSite Realty Corp. (NYSE:COR) in theS&PMidCap 400 effective prior to the opening of trading on Tuesday, December 28. S&P 500 / 100 constituent American Tower Corp. (NYSE:AMT) is acquiring CoreSite Realty in a deal expected to be completed soon pending final closing conditions.\nRepro Med Systems (NASDAQ:KRMD)+10%; today announcedFDA510(k) clearance that expands on-label use of the FREEDOM60 Infusion System to two additional subcutaneous Ig (SCIg) medications, Cutaquig®, manufactured by Octapharma, and Xembify®, manufactured by Grifols.\nCalamp Corp. (NASDAQ:CAMP)-14.9%; reported Q3 EPS of ($0.08), $0.16 worse than the analyst estimate of $0.08. Revenue for the quarter came in at $69 million versus the consensus estimate of $79.18 million.\nBlackBerry (NYSE:BB) -1.6%;reported Q3 EPS $0.00 vs $(0.07) Estimate,Sales $184.00M Beat $177.25M Estimate.","news_type":1,"symbols_score_info":{"ACST":0.9,"BB":0.9,"CAMP":0.9,"KRMD":0.9,"VOYA":0.9}},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":7073319,"gmtCreate":1640140516267,"gmtModify":1640140516368,"authorId":3585648549833646,"author":{"id":3585648549833646,"idStr":"3585648549833646","authorId":3585648549833646,"name":"onglaihuat","avatar":"https://static.tigerbbs.com/8beed4d730329353a71b58a536060ca8","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":691327054,"type":1,"supId":0,"prevId":0,"content":"g","text":"g","html":"g"}],"langContent":"CN"},{"id":691320158,"gmtCreate":1640138901108,"gmtModify":1640138901799,"author":{"id":"4087959350378170","authorId":"4087959350378170","name":"Jialatsia","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":7,"crmLevelSwitch":0,"authorIdStr":"4087959350378170","idStr":"4087959350378170"},"htmlText":"Meep","listText":"Meep","text":"Meep","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/691320158","repostId":1111567016,"repostType":4,"repost":{"id":"1111567016","kind":"news","pubTimestamp":1640133346,"share":"https://ttm.financial/m/news/1111567016?lang=&edition=full","pubTime":"2021-12-22 08:35","market":"us","language":"en","title":"After-Hours Stock Movers: Acasti Pharma,Calamp,BlackBerry and more","url":"https://stock-news.laohu8.com/highlight/detail?id=1111567016","media":"StreetInsider","summary":"After-Hours Stock Movers:\nAcasti Pharma (NASDAQ:ACST)+30%; Oppenheimer initiates coverage on Acasti ","content":"<p>After-Hours Stock Movers:</p>\n<p>Acasti Pharma (NASDAQ:ACST)<b>+30%</b>; Oppenheimer initiates coverage on Acasti Pharma (NASDAQ:ACST) with a Outperform rating and a price target of $6.00.</p>\n<p>Voya Financial (NYSE:VOYA)<b>+8%</b>; will replace CoreSite Realty Corp. (NYSE:COR) in theS&amp;PMidCap 400 effective prior to the opening of trading on Tuesday, December 28. S&amp;P 500 / 100 constituent American Tower Corp. (NYSE:AMT) is acquiring CoreSite Realty in a deal expected to be completed soon pending final closing conditions.</p>\n<p>Repro Med Systems (NASDAQ:KRMD)<b>+10%</b>; today announcedFDA510(k) clearance that expands on-label use of the FREEDOM60 Infusion System to two additional subcutaneous Ig (SCIg) medications, Cutaquig®, manufactured by Octapharma, and Xembify®, manufactured by Grifols.</p>\n<p>Calamp Corp. (NASDAQ:CAMP)<b>-14.9%</b>; reported Q3 EPS of ($0.08), $0.16 worse than the analyst estimate of $0.08. Revenue for the quarter came in at $69 million versus the consensus estimate of $79.18 million.</p>\n<p>BlackBerry&nbsp;(NYSE:BB)&nbsp;-1.6%;reported&nbsp;Q3 EPS $0.00 vs $(0.07) Estimate,Sales $184.00M Beat $177.25M Estimate.</p>","source":"highlight_streetinsider","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>After-Hours Stock Movers: Acasti Pharma,Calamp,BlackBerry and more</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAfter-Hours Stock Movers: Acasti Pharma,Calamp,BlackBerry and more\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-22 08:35 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.streetinsider.com/Special+Reports/After-Hours+Stock+Movers+1221%3A+%28ACST%29+%28VOYA%29+%28KRMD%29+Higher%2C+%28CAMP%29+Lower/19381258.html><strong>StreetInsider</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>After-Hours Stock Movers:\nAcasti Pharma (NASDAQ:ACST)+30%; Oppenheimer initiates coverage on Acasti Pharma (NASDAQ:ACST) with a Outperform rating and a price target of $6.00.\nVoya Financial (NYSE:VOYA...</p>\n\n<a href=\"https://www.streetinsider.com/Special+Reports/After-Hours+Stock+Movers+1221%3A+%28ACST%29+%28VOYA%29+%28KRMD%29+Higher%2C+%28CAMP%29+Lower/19381258.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"VOYA":"Voya Financial, Inc.","BB":"黑莓","CAMP":"Camp4 Therapeutics Corp.","KRMD":"Repro Med Systems, Inc."},"source_url":"https://www.streetinsider.com/Special+Reports/After-Hours+Stock+Movers+1221%3A+%28ACST%29+%28VOYA%29+%28KRMD%29+Higher%2C+%28CAMP%29+Lower/19381258.html","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1111567016","content_text":"After-Hours Stock Movers:\nAcasti Pharma (NASDAQ:ACST)+30%; Oppenheimer initiates coverage on Acasti Pharma (NASDAQ:ACST) with a Outperform rating and a price target of $6.00.\nVoya Financial (NYSE:VOYA)+8%; will replace CoreSite Realty Corp. (NYSE:COR) in theS&PMidCap 400 effective prior to the opening of trading on Tuesday, December 28. S&P 500 / 100 constituent American Tower Corp. (NYSE:AMT) is acquiring CoreSite Realty in a deal expected to be completed soon pending final closing conditions.\nRepro Med Systems (NASDAQ:KRMD)+10%; today announcedFDA510(k) clearance that expands on-label use of the FREEDOM60 Infusion System to two additional subcutaneous Ig (SCIg) medications, Cutaquig®, manufactured by Octapharma, and Xembify®, manufactured by Grifols.\nCalamp Corp. (NASDAQ:CAMP)-14.9%; reported Q3 EPS of ($0.08), $0.16 worse than the analyst estimate of $0.08. Revenue for the quarter came in at $69 million versus the consensus estimate of $79.18 million.\nBlackBerry (NYSE:BB) -1.6%;reported Q3 EPS $0.00 vs $(0.07) Estimate,Sales $184.00M Beat $177.25M Estimate.","news_type":1,"symbols_score_info":{"ACST":0.9,"BB":0.9,"CAMP":0.9,"KRMD":0.9,"VOYA":0.9}},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"},{"id":691363241,"gmtCreate":1640137822306,"gmtModify":1640137837157,"author":{"id":"3584490239949882","authorId":"3584490239949882","name":"Phyusin","avatar":"https://static.tigerbbs.com/73d7e61a3a910d1d25acb7dcee29f7ca","vip":1,"crmLevel":5,"crmLevelSwitch":0,"authorIdStr":"3584490239949882","idStr":"3584490239949882"},"htmlText":"Wow","listText":"Wow","text":"Wow","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/691363241","repostId":1111567016,"repostType":4,"repost":{"id":"1111567016","kind":"news","pubTimestamp":1640133346,"share":"https://ttm.financial/m/news/1111567016?lang=&edition=full","pubTime":"2021-12-22 08:35","market":"us","language":"en","title":"After-Hours Stock Movers: Acasti Pharma,Calamp,BlackBerry and more","url":"https://stock-news.laohu8.com/highlight/detail?id=1111567016","media":"StreetInsider","summary":"After-Hours Stock Movers:\nAcasti Pharma (NASDAQ:ACST)+30%; Oppenheimer initiates coverage on Acasti ","content":"<p>After-Hours Stock Movers:</p>\n<p>Acasti Pharma (NASDAQ:ACST)<b>+30%</b>; Oppenheimer initiates coverage on Acasti Pharma (NASDAQ:ACST) with a Outperform rating and a price target of $6.00.</p>\n<p>Voya Financial (NYSE:VOYA)<b>+8%</b>; will replace CoreSite Realty Corp. (NYSE:COR) in theS&amp;PMidCap 400 effective prior to the opening of trading on Tuesday, December 28. S&amp;P 500 / 100 constituent American Tower Corp. (NYSE:AMT) is acquiring CoreSite Realty in a deal expected to be completed soon pending final closing conditions.</p>\n<p>Repro Med Systems (NASDAQ:KRMD)<b>+10%</b>; today announcedFDA510(k) clearance that expands on-label use of the FREEDOM60 Infusion System to two additional subcutaneous Ig (SCIg) medications, Cutaquig®, manufactured by Octapharma, and Xembify®, manufactured by Grifols.</p>\n<p>Calamp Corp. (NASDAQ:CAMP)<b>-14.9%</b>; reported Q3 EPS of ($0.08), $0.16 worse than the analyst estimate of $0.08. Revenue for the quarter came in at $69 million versus the consensus estimate of $79.18 million.</p>\n<p>BlackBerry&nbsp;(NYSE:BB)&nbsp;-1.6%;reported&nbsp;Q3 EPS $0.00 vs $(0.07) Estimate,Sales $184.00M Beat $177.25M Estimate.</p>","source":"highlight_streetinsider","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>After-Hours Stock Movers: Acasti Pharma,Calamp,BlackBerry and more</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAfter-Hours Stock Movers: Acasti Pharma,Calamp,BlackBerry and more\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-22 08:35 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.streetinsider.com/Special+Reports/After-Hours+Stock+Movers+1221%3A+%28ACST%29+%28VOYA%29+%28KRMD%29+Higher%2C+%28CAMP%29+Lower/19381258.html><strong>StreetInsider</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>After-Hours Stock Movers:\nAcasti Pharma (NASDAQ:ACST)+30%; Oppenheimer initiates coverage on Acasti Pharma (NASDAQ:ACST) with a Outperform rating and a price target of $6.00.\nVoya Financial (NYSE:VOYA...</p>\n\n<a href=\"https://www.streetinsider.com/Special+Reports/After-Hours+Stock+Movers+1221%3A+%28ACST%29+%28VOYA%29+%28KRMD%29+Higher%2C+%28CAMP%29+Lower/19381258.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"VOYA":"Voya Financial, Inc.","BB":"黑莓","CAMP":"Camp4 Therapeutics Corp.","KRMD":"Repro Med Systems, Inc."},"source_url":"https://www.streetinsider.com/Special+Reports/After-Hours+Stock+Movers+1221%3A+%28ACST%29+%28VOYA%29+%28KRMD%29+Higher%2C+%28CAMP%29+Lower/19381258.html","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1111567016","content_text":"After-Hours Stock Movers:\nAcasti Pharma (NASDAQ:ACST)+30%; Oppenheimer initiates coverage on Acasti Pharma (NASDAQ:ACST) with a Outperform rating and a price target of $6.00.\nVoya Financial (NYSE:VOYA)+8%; will replace CoreSite Realty Corp. (NYSE:COR) in theS&PMidCap 400 effective prior to the opening of trading on Tuesday, December 28. S&P 500 / 100 constituent American Tower Corp. (NYSE:AMT) is acquiring CoreSite Realty in a deal expected to be completed soon pending final closing conditions.\nRepro Med Systems (NASDAQ:KRMD)+10%; today announcedFDA510(k) clearance that expands on-label use of the FREEDOM60 Infusion System to two additional subcutaneous Ig (SCIg) medications, Cutaquig®, manufactured by Octapharma, and Xembify®, manufactured by Grifols.\nCalamp Corp. (NASDAQ:CAMP)-14.9%; reported Q3 EPS of ($0.08), $0.16 worse than the analyst estimate of $0.08. Revenue for the quarter came in at $69 million versus the consensus estimate of $79.18 million.\nBlackBerry (NYSE:BB) -1.6%;reported Q3 EPS $0.00 vs $(0.07) Estimate,Sales $184.00M Beat $177.25M Estimate.","news_type":1,"symbols_score_info":{"ACST":0.9,"BB":0.9,"CAMP":0.9,"KRMD":0.9,"VOYA":0.9}},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"},{"id":691384859,"gmtCreate":1640137452475,"gmtModify":1640137452825,"author":{"id":"3578382329083125","authorId":"3578382329083125","name":"Hayleyxn","avatar":"https://static.tigerbbs.com/38f91d6f48b5ef2c23595e416b33bb59","vip":1,"crmLevel":2,"crmLevelSwitch":0,"authorIdStr":"3578382329083125","idStr":"3578382329083125"},"htmlText":"Oo","listText":"Oo","text":"Oo","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/691384859","repostId":1111567016,"repostType":4,"repost":{"id":"1111567016","kind":"news","pubTimestamp":1640133346,"share":"https://ttm.financial/m/news/1111567016?lang=&edition=full","pubTime":"2021-12-22 08:35","market":"us","language":"en","title":"After-Hours Stock Movers: Acasti Pharma,Calamp,BlackBerry and more","url":"https://stock-news.laohu8.com/highlight/detail?id=1111567016","media":"StreetInsider","summary":"After-Hours Stock Movers:\nAcasti Pharma (NASDAQ:ACST)+30%; Oppenheimer initiates coverage on Acasti ","content":"<p>After-Hours Stock Movers:</p>\n<p>Acasti Pharma (NASDAQ:ACST)<b>+30%</b>; Oppenheimer initiates coverage on Acasti Pharma (NASDAQ:ACST) with a Outperform rating and a price target of $6.00.</p>\n<p>Voya Financial (NYSE:VOYA)<b>+8%</b>; will replace CoreSite Realty Corp. (NYSE:COR) in theS&amp;PMidCap 400 effective prior to the opening of trading on Tuesday, December 28. S&amp;P 500 / 100 constituent American Tower Corp. (NYSE:AMT) is acquiring CoreSite Realty in a deal expected to be completed soon pending final closing conditions.</p>\n<p>Repro Med Systems (NASDAQ:KRMD)<b>+10%</b>; today announcedFDA510(k) clearance that expands on-label use of the FREEDOM60 Infusion System to two additional subcutaneous Ig (SCIg) medications, Cutaquig®, manufactured by Octapharma, and Xembify®, manufactured by Grifols.</p>\n<p>Calamp Corp. (NASDAQ:CAMP)<b>-14.9%</b>; reported Q3 EPS of ($0.08), $0.16 worse than the analyst estimate of $0.08. Revenue for the quarter came in at $69 million versus the consensus estimate of $79.18 million.</p>\n<p>BlackBerry&nbsp;(NYSE:BB)&nbsp;-1.6%;reported&nbsp;Q3 EPS $0.00 vs $(0.07) Estimate,Sales $184.00M Beat $177.25M Estimate.</p>","source":"highlight_streetinsider","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>After-Hours Stock Movers: Acasti Pharma,Calamp,BlackBerry and more</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAfter-Hours Stock Movers: Acasti Pharma,Calamp,BlackBerry and more\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-22 08:35 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.streetinsider.com/Special+Reports/After-Hours+Stock+Movers+1221%3A+%28ACST%29+%28VOYA%29+%28KRMD%29+Higher%2C+%28CAMP%29+Lower/19381258.html><strong>StreetInsider</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>After-Hours Stock Movers:\nAcasti Pharma (NASDAQ:ACST)+30%; Oppenheimer initiates coverage on Acasti Pharma (NASDAQ:ACST) with a Outperform rating and a price target of $6.00.\nVoya Financial (NYSE:VOYA...</p>\n\n<a href=\"https://www.streetinsider.com/Special+Reports/After-Hours+Stock+Movers+1221%3A+%28ACST%29+%28VOYA%29+%28KRMD%29+Higher%2C+%28CAMP%29+Lower/19381258.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"VOYA":"Voya Financial, Inc.","BB":"黑莓","CAMP":"Camp4 Therapeutics Corp.","KRMD":"Repro Med Systems, Inc."},"source_url":"https://www.streetinsider.com/Special+Reports/After-Hours+Stock+Movers+1221%3A+%28ACST%29+%28VOYA%29+%28KRMD%29+Higher%2C+%28CAMP%29+Lower/19381258.html","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1111567016","content_text":"After-Hours Stock Movers:\nAcasti Pharma (NASDAQ:ACST)+30%; Oppenheimer initiates coverage on Acasti Pharma (NASDAQ:ACST) with a Outperform rating and a price target of $6.00.\nVoya Financial (NYSE:VOYA)+8%; will replace CoreSite Realty Corp. (NYSE:COR) in theS&PMidCap 400 effective prior to the opening of trading on Tuesday, December 28. S&P 500 / 100 constituent American Tower Corp. (NYSE:AMT) is acquiring CoreSite Realty in a deal expected to be completed soon pending final closing conditions.\nRepro Med Systems (NASDAQ:KRMD)+10%; today announcedFDA510(k) clearance that expands on-label use of the FREEDOM60 Infusion System to two additional subcutaneous Ig (SCIg) medications, Cutaquig®, manufactured by Octapharma, and Xembify®, manufactured by Grifols.\nCalamp Corp. (NASDAQ:CAMP)-14.9%; reported Q3 EPS of ($0.08), $0.16 worse than the analyst estimate of $0.08. Revenue for the quarter came in at $69 million versus the consensus estimate of $79.18 million.\nBlackBerry (NYSE:BB) -1.6%;reported Q3 EPS $0.00 vs $(0.07) Estimate,Sales $184.00M Beat $177.25M Estimate.","news_type":1,"symbols_score_info":{"ACST":0.9,"BB":0.9,"CAMP":0.9,"KRMD":0.9,"VOYA":0.9}},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":7072748,"gmtCreate":1640137458235,"gmtModify":1640137458322,"authorId":3578382329083125,"author":{"id":3578382329083125,"idStr":"3578382329083125","authorId":3578382329083125,"name":"Hayleyxn","avatar":"https://static.tigerbbs.com/38f91d6f48b5ef2c23595e416b33bb59","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":691384859,"type":1,"supId":0,"prevId":0,"content":"ok","text":"ok","html":"ok"}],"langContent":"CN"},{"id":691383402,"gmtCreate":1640136915930,"gmtModify":1640136958137,"author":{"id":"3574326723774097","authorId":"3574326723774097","name":"Gackky","avatar":"https://static.tigerbbs.com/5898b44bf5a31bf2b9d4e37227ed8177","vip":1,"crmLevel":3,"crmLevelSwitch":0,"authorIdStr":"3574326723774097","idStr":"3574326723774097"},"htmlText":"blackberry wow.. after years of lying low[Sly]&nbsp;","listText":"blackberry wow.. after years of lying low[Sly]&nbsp;","text":"blackberry wow.. after years of lying low[Sly]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/691383402","repostId":1111567016,"repostType":4,"repost":{"id":"1111567016","kind":"news","pubTimestamp":1640133346,"share":"https://ttm.financial/m/news/1111567016?lang=&edition=full","pubTime":"2021-12-22 08:35","market":"us","language":"en","title":"After-Hours Stock Movers: Acasti Pharma,Calamp,BlackBerry and more","url":"https://stock-news.laohu8.com/highlight/detail?id=1111567016","media":"StreetInsider","summary":"After-Hours Stock Movers:\nAcasti Pharma (NASDAQ:ACST)+30%; Oppenheimer initiates coverage on Acasti ","content":"<p>After-Hours Stock Movers:</p>\n<p>Acasti Pharma (NASDAQ:ACST)<b>+30%</b>; Oppenheimer initiates coverage on Acasti Pharma (NASDAQ:ACST) with a Outperform rating and a price target of $6.00.</p>\n<p>Voya Financial (NYSE:VOYA)<b>+8%</b>; will replace CoreSite Realty Corp. (NYSE:COR) in theS&amp;PMidCap 400 effective prior to the opening of trading on Tuesday, December 28. S&amp;P 500 / 100 constituent American Tower Corp. (NYSE:AMT) is acquiring CoreSite Realty in a deal expected to be completed soon pending final closing conditions.</p>\n<p>Repro Med Systems (NASDAQ:KRMD)<b>+10%</b>; today announcedFDA510(k) clearance that expands on-label use of the FREEDOM60 Infusion System to two additional subcutaneous Ig (SCIg) medications, Cutaquig®, manufactured by Octapharma, and Xembify®, manufactured by Grifols.</p>\n<p>Calamp Corp. (NASDAQ:CAMP)<b>-14.9%</b>; reported Q3 EPS of ($0.08), $0.16 worse than the analyst estimate of $0.08. Revenue for the quarter came in at $69 million versus the consensus estimate of $79.18 million.</p>\n<p>BlackBerry&nbsp;(NYSE:BB)&nbsp;-1.6%;reported&nbsp;Q3 EPS $0.00 vs $(0.07) Estimate,Sales $184.00M Beat $177.25M Estimate.</p>","source":"highlight_streetinsider","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>After-Hours Stock Movers: Acasti Pharma,Calamp,BlackBerry and more</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAfter-Hours Stock Movers: Acasti Pharma,Calamp,BlackBerry and more\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-22 08:35 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.streetinsider.com/Special+Reports/After-Hours+Stock+Movers+1221%3A+%28ACST%29+%28VOYA%29+%28KRMD%29+Higher%2C+%28CAMP%29+Lower/19381258.html><strong>StreetInsider</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>After-Hours Stock Movers:\nAcasti Pharma (NASDAQ:ACST)+30%; Oppenheimer initiates coverage on Acasti Pharma (NASDAQ:ACST) with a Outperform rating and a price target of $6.00.\nVoya Financial (NYSE:VOYA...</p>\n\n<a href=\"https://www.streetinsider.com/Special+Reports/After-Hours+Stock+Movers+1221%3A+%28ACST%29+%28VOYA%29+%28KRMD%29+Higher%2C+%28CAMP%29+Lower/19381258.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"VOYA":"Voya Financial, Inc.","BB":"黑莓","CAMP":"Camp4 Therapeutics Corp.","KRMD":"Repro Med Systems, Inc."},"source_url":"https://www.streetinsider.com/Special+Reports/After-Hours+Stock+Movers+1221%3A+%28ACST%29+%28VOYA%29+%28KRMD%29+Higher%2C+%28CAMP%29+Lower/19381258.html","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1111567016","content_text":"After-Hours Stock Movers:\nAcasti Pharma (NASDAQ:ACST)+30%; Oppenheimer initiates coverage on Acasti Pharma (NASDAQ:ACST) with a Outperform rating and a price target of $6.00.\nVoya Financial (NYSE:VOYA)+8%; will replace CoreSite Realty Corp. (NYSE:COR) in theS&PMidCap 400 effective prior to the opening of trading on Tuesday, December 28. S&P 500 / 100 constituent American Tower Corp. (NYSE:AMT) is acquiring CoreSite Realty in a deal expected to be completed soon pending final closing conditions.\nRepro Med Systems (NASDAQ:KRMD)+10%; today announcedFDA510(k) clearance that expands on-label use of the FREEDOM60 Infusion System to two additional subcutaneous Ig (SCIg) medications, Cutaquig®, manufactured by Octapharma, and Xembify®, manufactured by Grifols.\nCalamp Corp. (NASDAQ:CAMP)-14.9%; reported Q3 EPS of ($0.08), $0.16 worse than the analyst estimate of $0.08. Revenue for the quarter came in at $69 million versus the consensus estimate of $79.18 million.\nBlackBerry (NYSE:BB) -1.6%;reported Q3 EPS $0.00 vs $(0.07) Estimate,Sales $184.00M Beat $177.25M Estimate.","news_type":1,"symbols_score_info":{"ACST":0.9,"BB":0.9,"CAMP":0.9,"KRMD":0.9,"VOYA":0.9}},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":7075561,"gmtCreate":1640160614517,"gmtModify":1640160614517,"authorId":3566385558470298,"author":{"id":3566385558470298,"idStr":"3566385558470298","authorId":3566385558470298,"name":"Venus_M","avatar":"https://static.tigerbbs.com/525433622d774840840ddaacaf2281d2","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":691383402,"type":1,"supId":0,"prevId":0,"content":"only move a little <u>bit</u>","text":"only move a little <u>bit</u>","html":"only move a little <u>bit</u>"},{"id":7073207,"gmtCreate":1640139943768,"gmtModify":1640139943801,"authorId":4099650032870960,"author":{"id":4099650032870960,"idStr":"4099650032870960","authorId":4099650032870960,"name":"Helloyah","avatar":"https://static.tigerbbs.com/04a600ad88159fff17f3cf715916ac3a","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":691383402,"type":1,"supId":0,"prevId":0,"content":"<u>agree</u>","text":"<u>agree</u>","html":"<u>agree</u>"},{"id":7072826,"gmtCreate":1640137830506,"gmtModify":1640137830541,"authorId":3570369418287680,"author":{"id":3570369418287680,"idStr":"3570369418287680","authorId":3570369418287680,"name":"JohnL","avatar":"https://static.tigerbbs.com/7b66d4064f2df5806740a5c2fbf75ca6","vip":1,"crmLevel":5,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":691383402,"type":1,"supId":0,"prevId":0,"content":"<u>Yes</u>","text":"<u>Yes</u>","html":"<u>Yes</u>"}],"langContent":"CN"},{"id":691317465,"gmtCreate":1640136652586,"gmtModify":1640136652893,"author":{"id":"3579242284896142","authorId":"3579242284896142","name":"CherryPang","avatar":"https://static.tigerbbs.com/72256d5f02e9431fb7df955e5b3418f8","vip":1,"crmLevel":6,"crmLevelSwitch":0,"authorIdStr":"3579242284896142","idStr":"3579242284896142"},"htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/691317465","repostId":1111567016,"repostType":4,"repost":{"id":"1111567016","kind":"news","pubTimestamp":1640133346,"share":"https://ttm.financial/m/news/1111567016?lang=&edition=full","pubTime":"2021-12-22 08:35","market":"us","language":"en","title":"After-Hours Stock Movers: Acasti Pharma,Calamp,BlackBerry and more","url":"https://stock-news.laohu8.com/highlight/detail?id=1111567016","media":"StreetInsider","summary":"After-Hours Stock Movers:\nAcasti Pharma (NASDAQ:ACST)+30%; Oppenheimer initiates coverage on Acasti ","content":"<p>After-Hours Stock Movers:</p>\n<p>Acasti Pharma (NASDAQ:ACST)<b>+30%</b>; Oppenheimer initiates coverage on Acasti Pharma (NASDAQ:ACST) with a Outperform rating and a price target of $6.00.</p>\n<p>Voya Financial (NYSE:VOYA)<b>+8%</b>; will replace CoreSite Realty Corp. (NYSE:COR) in theS&amp;PMidCap 400 effective prior to the opening of trading on Tuesday, December 28. S&amp;P 500 / 100 constituent American Tower Corp. (NYSE:AMT) is acquiring CoreSite Realty in a deal expected to be completed soon pending final closing conditions.</p>\n<p>Repro Med Systems (NASDAQ:KRMD)<b>+10%</b>; today announcedFDA510(k) clearance that expands on-label use of the FREEDOM60 Infusion System to two additional subcutaneous Ig (SCIg) medications, Cutaquig®, manufactured by Octapharma, and Xembify®, manufactured by Grifols.</p>\n<p>Calamp Corp. (NASDAQ:CAMP)<b>-14.9%</b>; reported Q3 EPS of ($0.08), $0.16 worse than the analyst estimate of $0.08. Revenue for the quarter came in at $69 million versus the consensus estimate of $79.18 million.</p>\n<p>BlackBerry&nbsp;(NYSE:BB)&nbsp;-1.6%;reported&nbsp;Q3 EPS $0.00 vs $(0.07) Estimate,Sales $184.00M Beat $177.25M Estimate.</p>","source":"highlight_streetinsider","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>After-Hours Stock Movers: Acasti Pharma,Calamp,BlackBerry and more</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAfter-Hours Stock Movers: Acasti Pharma,Calamp,BlackBerry and more\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-22 08:35 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.streetinsider.com/Special+Reports/After-Hours+Stock+Movers+1221%3A+%28ACST%29+%28VOYA%29+%28KRMD%29+Higher%2C+%28CAMP%29+Lower/19381258.html><strong>StreetInsider</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>After-Hours Stock Movers:\nAcasti Pharma (NASDAQ:ACST)+30%; Oppenheimer initiates coverage on Acasti Pharma (NASDAQ:ACST) with a Outperform rating and a price target of $6.00.\nVoya Financial (NYSE:VOYA...</p>\n\n<a href=\"https://www.streetinsider.com/Special+Reports/After-Hours+Stock+Movers+1221%3A+%28ACST%29+%28VOYA%29+%28KRMD%29+Higher%2C+%28CAMP%29+Lower/19381258.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"VOYA":"Voya Financial, Inc.","BB":"黑莓","CAMP":"Camp4 Therapeutics Corp.","KRMD":"Repro Med Systems, Inc."},"source_url":"https://www.streetinsider.com/Special+Reports/After-Hours+Stock+Movers+1221%3A+%28ACST%29+%28VOYA%29+%28KRMD%29+Higher%2C+%28CAMP%29+Lower/19381258.html","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1111567016","content_text":"After-Hours Stock Movers:\nAcasti Pharma (NASDAQ:ACST)+30%; Oppenheimer initiates coverage on Acasti Pharma (NASDAQ:ACST) with a Outperform rating and a price target of $6.00.\nVoya Financial (NYSE:VOYA)+8%; will replace CoreSite Realty Corp. (NYSE:COR) in theS&PMidCap 400 effective prior to the opening of trading on Tuesday, December 28. S&P 500 / 100 constituent American Tower Corp. (NYSE:AMT) is acquiring CoreSite Realty in a deal expected to be completed soon pending final closing conditions.\nRepro Med Systems (NASDAQ:KRMD)+10%; today announcedFDA510(k) clearance that expands on-label use of the FREEDOM60 Infusion System to two additional subcutaneous Ig (SCIg) medications, Cutaquig®, manufactured by Octapharma, and Xembify®, manufactured by Grifols.\nCalamp Corp. (NASDAQ:CAMP)-14.9%; reported Q3 EPS of ($0.08), $0.16 worse than the analyst estimate of $0.08. Revenue for the quarter came in at $69 million versus the consensus estimate of $79.18 million.\nBlackBerry (NYSE:BB) -1.6%;reported Q3 EPS $0.00 vs $(0.07) Estimate,Sales $184.00M Beat $177.25M Estimate.","news_type":1,"symbols_score_info":{"ACST":0.9,"BB":0.9,"CAMP":0.9,"KRMD":0.9,"VOYA":0.9}},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"},{"id":691319971,"gmtCreate":1640135783940,"gmtModify":1640135784337,"author":{"id":"3553595575003751","authorId":"3553595575003751","name":"Juanlee","avatar":"https://static.tigerbbs.com/fbf36c4a5cfcee186a3187df34efc7f9","vip":1,"crmLevel":2,"crmLevelSwitch":0,"authorIdStr":"3553595575003751","idStr":"3553595575003751"},"htmlText":"Blackberry&nbsp; germinating","listText":"Blackberry&nbsp; germinating","text":"Blackberry germinating","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/691319971","repostId":1111567016,"repostType":4,"repost":{"id":"1111567016","kind":"news","pubTimestamp":1640133346,"share":"https://ttm.financial/m/news/1111567016?lang=&edition=full","pubTime":"2021-12-22 08:35","market":"us","language":"en","title":"After-Hours Stock Movers: Acasti Pharma,Calamp,BlackBerry and more","url":"https://stock-news.laohu8.com/highlight/detail?id=1111567016","media":"StreetInsider","summary":"After-Hours Stock Movers:\nAcasti Pharma (NASDAQ:ACST)+30%; Oppenheimer initiates coverage on Acasti ","content":"<p>After-Hours Stock Movers:</p>\n<p>Acasti Pharma (NASDAQ:ACST)<b>+30%</b>; Oppenheimer initiates coverage on Acasti Pharma (NASDAQ:ACST) with a Outperform rating and a price target of $6.00.</p>\n<p>Voya Financial (NYSE:VOYA)<b>+8%</b>; will replace CoreSite Realty Corp. (NYSE:COR) in theS&amp;PMidCap 400 effective prior to the opening of trading on Tuesday, December 28. S&amp;P 500 / 100 constituent American Tower Corp. (NYSE:AMT) is acquiring CoreSite Realty in a deal expected to be completed soon pending final closing conditions.</p>\n<p>Repro Med Systems (NASDAQ:KRMD)<b>+10%</b>; today announcedFDA510(k) clearance that expands on-label use of the FREEDOM60 Infusion System to two additional subcutaneous Ig (SCIg) medications, Cutaquig®, manufactured by Octapharma, and Xembify®, manufactured by Grifols.</p>\n<p>Calamp Corp. (NASDAQ:CAMP)<b>-14.9%</b>; reported Q3 EPS of ($0.08), $0.16 worse than the analyst estimate of $0.08. Revenue for the quarter came in at $69 million versus the consensus estimate of $79.18 million.</p>\n<p>BlackBerry&nbsp;(NYSE:BB)&nbsp;-1.6%;reported&nbsp;Q3 EPS $0.00 vs $(0.07) Estimate,Sales $184.00M Beat $177.25M Estimate.</p>","source":"highlight_streetinsider","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>After-Hours Stock Movers: Acasti Pharma,Calamp,BlackBerry and more</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAfter-Hours Stock Movers: Acasti Pharma,Calamp,BlackBerry and more\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-22 08:35 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.streetinsider.com/Special+Reports/After-Hours+Stock+Movers+1221%3A+%28ACST%29+%28VOYA%29+%28KRMD%29+Higher%2C+%28CAMP%29+Lower/19381258.html><strong>StreetInsider</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>After-Hours Stock Movers:\nAcasti Pharma (NASDAQ:ACST)+30%; Oppenheimer initiates coverage on Acasti Pharma (NASDAQ:ACST) with a Outperform rating and a price target of $6.00.\nVoya Financial (NYSE:VOYA...</p>\n\n<a href=\"https://www.streetinsider.com/Special+Reports/After-Hours+Stock+Movers+1221%3A+%28ACST%29+%28VOYA%29+%28KRMD%29+Higher%2C+%28CAMP%29+Lower/19381258.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"VOYA":"Voya Financial, Inc.","BB":"黑莓","CAMP":"Camp4 Therapeutics Corp.","KRMD":"Repro Med Systems, Inc."},"source_url":"https://www.streetinsider.com/Special+Reports/After-Hours+Stock+Movers+1221%3A+%28ACST%29+%28VOYA%29+%28KRMD%29+Higher%2C+%28CAMP%29+Lower/19381258.html","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1111567016","content_text":"After-Hours Stock Movers:\nAcasti Pharma (NASDAQ:ACST)+30%; Oppenheimer initiates coverage on Acasti Pharma (NASDAQ:ACST) with a Outperform rating and a price target of $6.00.\nVoya Financial (NYSE:VOYA)+8%; will replace CoreSite Realty Corp. (NYSE:COR) in theS&PMidCap 400 effective prior to the opening of trading on Tuesday, December 28. S&P 500 / 100 constituent American Tower Corp. (NYSE:AMT) is acquiring CoreSite Realty in a deal expected to be completed soon pending final closing conditions.\nRepro Med Systems (NASDAQ:KRMD)+10%; today announcedFDA510(k) clearance that expands on-label use of the FREEDOM60 Infusion System to two additional subcutaneous Ig (SCIg) medications, Cutaquig®, manufactured by Octapharma, and Xembify®, manufactured by Grifols.\nCalamp Corp. (NASDAQ:CAMP)-14.9%; reported Q3 EPS of ($0.08), $0.16 worse than the analyst estimate of $0.08. Revenue for the quarter came in at $69 million versus the consensus estimate of $79.18 million.\nBlackBerry (NYSE:BB) -1.6%;reported Q3 EPS $0.00 vs $(0.07) Estimate,Sales $184.00M Beat $177.25M Estimate.","news_type":1,"symbols_score_info":{"ACST":0.9,"BB":0.9,"CAMP":0.9,"KRMD":0.9,"VOYA":0.9}},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"},{"id":691310459,"gmtCreate":1640135737776,"gmtModify":1640135738290,"author":{"id":"3574204999726623","authorId":"3574204999726623","name":"Ssimsim","avatar":"https://static.tigerbbs.com/a43eabdde1f739ca3b75e3dbfb7f3531","vip":1,"crmLevel":5,"crmLevelSwitch":0,"authorIdStr":"3574204999726623","idStr":"3574204999726623"},"htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/691310459","repostId":1111567016,"repostType":4,"repost":{"id":"1111567016","kind":"news","pubTimestamp":1640133346,"share":"https://ttm.financial/m/news/1111567016?lang=&edition=full","pubTime":"2021-12-22 08:35","market":"us","language":"en","title":"After-Hours Stock Movers: Acasti Pharma,Calamp,BlackBerry and more","url":"https://stock-news.laohu8.com/highlight/detail?id=1111567016","media":"StreetInsider","summary":"After-Hours Stock Movers:\nAcasti Pharma (NASDAQ:ACST)+30%; Oppenheimer initiates coverage on Acasti ","content":"<p>After-Hours Stock Movers:</p>\n<p>Acasti Pharma (NASDAQ:ACST)<b>+30%</b>; Oppenheimer initiates coverage on Acasti Pharma (NASDAQ:ACST) with a Outperform rating and a price target of $6.00.</p>\n<p>Voya Financial (NYSE:VOYA)<b>+8%</b>; will replace CoreSite Realty Corp. (NYSE:COR) in theS&amp;PMidCap 400 effective prior to the opening of trading on Tuesday, December 28. S&amp;P 500 / 100 constituent American Tower Corp. (NYSE:AMT) is acquiring CoreSite Realty in a deal expected to be completed soon pending final closing conditions.</p>\n<p>Repro Med Systems (NASDAQ:KRMD)<b>+10%</b>; today announcedFDA510(k) clearance that expands on-label use of the FREEDOM60 Infusion System to two additional subcutaneous Ig (SCIg) medications, Cutaquig®, manufactured by Octapharma, and Xembify®, manufactured by Grifols.</p>\n<p>Calamp Corp. (NASDAQ:CAMP)<b>-14.9%</b>; reported Q3 EPS of ($0.08), $0.16 worse than the analyst estimate of $0.08. Revenue for the quarter came in at $69 million versus the consensus estimate of $79.18 million.</p>\n<p>BlackBerry&nbsp;(NYSE:BB)&nbsp;-1.6%;reported&nbsp;Q3 EPS $0.00 vs $(0.07) Estimate,Sales $184.00M Beat $177.25M Estimate.</p>","source":"highlight_streetinsider","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>After-Hours Stock Movers: Acasti Pharma,Calamp,BlackBerry and more</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAfter-Hours Stock Movers: Acasti Pharma,Calamp,BlackBerry and more\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-22 08:35 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.streetinsider.com/Special+Reports/After-Hours+Stock+Movers+1221%3A+%28ACST%29+%28VOYA%29+%28KRMD%29+Higher%2C+%28CAMP%29+Lower/19381258.html><strong>StreetInsider</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>After-Hours Stock Movers:\nAcasti Pharma (NASDAQ:ACST)+30%; Oppenheimer initiates coverage on Acasti Pharma (NASDAQ:ACST) with a Outperform rating and a price target of $6.00.\nVoya Financial (NYSE:VOYA...</p>\n\n<a href=\"https://www.streetinsider.com/Special+Reports/After-Hours+Stock+Movers+1221%3A+%28ACST%29+%28VOYA%29+%28KRMD%29+Higher%2C+%28CAMP%29+Lower/19381258.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"VOYA":"Voya Financial, Inc.","BB":"黑莓","CAMP":"Camp4 Therapeutics Corp.","KRMD":"Repro Med Systems, Inc."},"source_url":"https://www.streetinsider.com/Special+Reports/After-Hours+Stock+Movers+1221%3A+%28ACST%29+%28VOYA%29+%28KRMD%29+Higher%2C+%28CAMP%29+Lower/19381258.html","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1111567016","content_text":"After-Hours Stock Movers:\nAcasti Pharma (NASDAQ:ACST)+30%; Oppenheimer initiates coverage on Acasti Pharma (NASDAQ:ACST) with a Outperform rating and a price target of $6.00.\nVoya Financial (NYSE:VOYA)+8%; will replace CoreSite Realty Corp. (NYSE:COR) in theS&PMidCap 400 effective prior to the opening of trading on Tuesday, December 28. S&P 500 / 100 constituent American Tower Corp. (NYSE:AMT) is acquiring CoreSite Realty in a deal expected to be completed soon pending final closing conditions.\nRepro Med Systems (NASDAQ:KRMD)+10%; today announcedFDA510(k) clearance that expands on-label use of the FREEDOM60 Infusion System to two additional subcutaneous Ig (SCIg) medications, Cutaquig®, manufactured by Octapharma, and Xembify®, manufactured by Grifols.\nCalamp Corp. (NASDAQ:CAMP)-14.9%; reported Q3 EPS of ($0.08), $0.16 worse than the analyst estimate of $0.08. Revenue for the quarter came in at $69 million versus the consensus estimate of $79.18 million.\nBlackBerry (NYSE:BB) -1.6%;reported Q3 EPS $0.00 vs $(0.07) Estimate,Sales $184.00M Beat $177.25M Estimate.","news_type":1,"symbols_score_info":{"ACST":0.9,"BB":0.9,"CAMP":0.9,"KRMD":0.9,"VOYA":0.9}},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"},{"id":691334520,"gmtCreate":1640135447880,"gmtModify":1640135448279,"author":{"id":"4089085863454690","authorId":"4089085863454690","name":"Leekeez","avatar":"https://static.tigerbbs.com/0dc7b69aff39f86a9dc2217fe596c9af","vip":1,"crmLevel":4,"crmLevelSwitch":0,"authorIdStr":"4089085863454690","idStr":"4089085863454690"},"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/691334520","repostId":1111567016,"repostType":4,"repost":{"id":"1111567016","kind":"news","pubTimestamp":1640133346,"share":"https://ttm.financial/m/news/1111567016?lang=&edition=full","pubTime":"2021-12-22 08:35","market":"us","language":"en","title":"After-Hours Stock Movers: Acasti Pharma,Calamp,BlackBerry and more","url":"https://stock-news.laohu8.com/highlight/detail?id=1111567016","media":"StreetInsider","summary":"After-Hours Stock Movers:\nAcasti Pharma (NASDAQ:ACST)+30%; Oppenheimer initiates coverage on Acasti ","content":"<p>After-Hours Stock Movers:</p>\n<p>Acasti Pharma (NASDAQ:ACST)<b>+30%</b>; Oppenheimer initiates coverage on Acasti Pharma (NASDAQ:ACST) with a Outperform rating and a price target of $6.00.</p>\n<p>Voya Financial (NYSE:VOYA)<b>+8%</b>; will replace CoreSite Realty Corp. (NYSE:COR) in theS&amp;PMidCap 400 effective prior to the opening of trading on Tuesday, December 28. S&amp;P 500 / 100 constituent American Tower Corp. (NYSE:AMT) is acquiring CoreSite Realty in a deal expected to be completed soon pending final closing conditions.</p>\n<p>Repro Med Systems (NASDAQ:KRMD)<b>+10%</b>; today announcedFDA510(k) clearance that expands on-label use of the FREEDOM60 Infusion System to two additional subcutaneous Ig (SCIg) medications, Cutaquig®, manufactured by Octapharma, and Xembify®, manufactured by Grifols.</p>\n<p>Calamp Corp. (NASDAQ:CAMP)<b>-14.9%</b>; reported Q3 EPS of ($0.08), $0.16 worse than the analyst estimate of $0.08. Revenue for the quarter came in at $69 million versus the consensus estimate of $79.18 million.</p>\n<p>BlackBerry&nbsp;(NYSE:BB)&nbsp;-1.6%;reported&nbsp;Q3 EPS $0.00 vs $(0.07) Estimate,Sales $184.00M Beat $177.25M Estimate.</p>","source":"highlight_streetinsider","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>After-Hours Stock Movers: Acasti Pharma,Calamp,BlackBerry and more</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAfter-Hours Stock Movers: Acasti Pharma,Calamp,BlackBerry and more\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-22 08:35 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.streetinsider.com/Special+Reports/After-Hours+Stock+Movers+1221%3A+%28ACST%29+%28VOYA%29+%28KRMD%29+Higher%2C+%28CAMP%29+Lower/19381258.html><strong>StreetInsider</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>After-Hours Stock Movers:\nAcasti Pharma (NASDAQ:ACST)+30%; Oppenheimer initiates coverage on Acasti Pharma (NASDAQ:ACST) with a Outperform rating and a price target of $6.00.\nVoya Financial (NYSE:VOYA...</p>\n\n<a href=\"https://www.streetinsider.com/Special+Reports/After-Hours+Stock+Movers+1221%3A+%28ACST%29+%28VOYA%29+%28KRMD%29+Higher%2C+%28CAMP%29+Lower/19381258.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"VOYA":"Voya Financial, Inc.","BB":"黑莓","CAMP":"Camp4 Therapeutics Corp.","KRMD":"Repro Med Systems, Inc."},"source_url":"https://www.streetinsider.com/Special+Reports/After-Hours+Stock+Movers+1221%3A+%28ACST%29+%28VOYA%29+%28KRMD%29+Higher%2C+%28CAMP%29+Lower/19381258.html","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1111567016","content_text":"After-Hours Stock Movers:\nAcasti Pharma (NASDAQ:ACST)+30%; Oppenheimer initiates coverage on Acasti Pharma (NASDAQ:ACST) with a Outperform rating and a price target of $6.00.\nVoya Financial (NYSE:VOYA)+8%; will replace CoreSite Realty Corp. (NYSE:COR) in theS&PMidCap 400 effective prior to the opening of trading on Tuesday, December 28. S&P 500 / 100 constituent American Tower Corp. (NYSE:AMT) is acquiring CoreSite Realty in a deal expected to be completed soon pending final closing conditions.\nRepro Med Systems (NASDAQ:KRMD)+10%; today announcedFDA510(k) clearance that expands on-label use of the FREEDOM60 Infusion System to two additional subcutaneous Ig (SCIg) medications, Cutaquig®, manufactured by Octapharma, and Xembify®, manufactured by Grifols.\nCalamp Corp. (NASDAQ:CAMP)-14.9%; reported Q3 EPS of ($0.08), $0.16 worse than the analyst estimate of $0.08. Revenue for the quarter came in at $69 million versus the consensus estimate of $79.18 million.\nBlackBerry (NYSE:BB) -1.6%;reported Q3 EPS $0.00 vs $(0.07) Estimate,Sales $184.00M Beat $177.25M Estimate.","news_type":1,"symbols_score_info":{"ACST":0.9,"BB":0.9,"CAMP":0.9,"KRMD":0.9,"VOYA":0.9}},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"},{"id":691332375,"gmtCreate":1640135144106,"gmtModify":1640138778642,"author":{"id":"3571482048865852","authorId":"3571482048865852","name":"Troytan","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":4,"crmLevelSwitch":0,"authorIdStr":"3571482048865852","idStr":"3571482048865852"},"htmlText":"BB back to life","listText":"BB back to life","text":"BB back to life","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/691332375","repostId":1111567016,"repostType":4,"repost":{"id":"1111567016","kind":"news","pubTimestamp":1640133346,"share":"https://ttm.financial/m/news/1111567016?lang=&edition=full","pubTime":"2021-12-22 08:35","market":"us","language":"en","title":"After-Hours Stock Movers: Acasti Pharma,Calamp,BlackBerry and more","url":"https://stock-news.laohu8.com/highlight/detail?id=1111567016","media":"StreetInsider","summary":"After-Hours Stock Movers:\nAcasti Pharma (NASDAQ:ACST)+30%; Oppenheimer initiates coverage on Acasti ","content":"<p>After-Hours Stock Movers:</p>\n<p>Acasti Pharma (NASDAQ:ACST)<b>+30%</b>; Oppenheimer initiates coverage on Acasti Pharma (NASDAQ:ACST) with a Outperform rating and a price target of $6.00.</p>\n<p>Voya Financial (NYSE:VOYA)<b>+8%</b>; will replace CoreSite Realty Corp. (NYSE:COR) in theS&amp;PMidCap 400 effective prior to the opening of trading on Tuesday, December 28. S&amp;P 500 / 100 constituent American Tower Corp. (NYSE:AMT) is acquiring CoreSite Realty in a deal expected to be completed soon pending final closing conditions.</p>\n<p>Repro Med Systems (NASDAQ:KRMD)<b>+10%</b>; today announcedFDA510(k) clearance that expands on-label use of the FREEDOM60 Infusion System to two additional subcutaneous Ig (SCIg) medications, Cutaquig®, manufactured by Octapharma, and Xembify®, manufactured by Grifols.</p>\n<p>Calamp Corp. (NASDAQ:CAMP)<b>-14.9%</b>; reported Q3 EPS of ($0.08), $0.16 worse than the analyst estimate of $0.08. Revenue for the quarter came in at $69 million versus the consensus estimate of $79.18 million.</p>\n<p>BlackBerry&nbsp;(NYSE:BB)&nbsp;-1.6%;reported&nbsp;Q3 EPS $0.00 vs $(0.07) Estimate,Sales $184.00M Beat $177.25M Estimate.</p>","source":"highlight_streetinsider","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>After-Hours Stock Movers: Acasti Pharma,Calamp,BlackBerry and more</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAfter-Hours Stock Movers: Acasti Pharma,Calamp,BlackBerry and more\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-22 08:35 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.streetinsider.com/Special+Reports/After-Hours+Stock+Movers+1221%3A+%28ACST%29+%28VOYA%29+%28KRMD%29+Higher%2C+%28CAMP%29+Lower/19381258.html><strong>StreetInsider</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>After-Hours Stock Movers:\nAcasti Pharma (NASDAQ:ACST)+30%; Oppenheimer initiates coverage on Acasti Pharma (NASDAQ:ACST) with a Outperform rating and a price target of $6.00.\nVoya Financial (NYSE:VOYA...</p>\n\n<a href=\"https://www.streetinsider.com/Special+Reports/After-Hours+Stock+Movers+1221%3A+%28ACST%29+%28VOYA%29+%28KRMD%29+Higher%2C+%28CAMP%29+Lower/19381258.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"VOYA":"Voya Financial, Inc.","BB":"黑莓","CAMP":"Camp4 Therapeutics Corp.","KRMD":"Repro Med Systems, Inc."},"source_url":"https://www.streetinsider.com/Special+Reports/After-Hours+Stock+Movers+1221%3A+%28ACST%29+%28VOYA%29+%28KRMD%29+Higher%2C+%28CAMP%29+Lower/19381258.html","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1111567016","content_text":"After-Hours Stock Movers:\nAcasti Pharma (NASDAQ:ACST)+30%; Oppenheimer initiates coverage on Acasti Pharma (NASDAQ:ACST) with a Outperform rating and a price target of $6.00.\nVoya Financial (NYSE:VOYA)+8%; will replace CoreSite Realty Corp. (NYSE:COR) in theS&PMidCap 400 effective prior to the opening of trading on Tuesday, December 28. S&P 500 / 100 constituent American Tower Corp. (NYSE:AMT) is acquiring CoreSite Realty in a deal expected to be completed soon pending final closing conditions.\nRepro Med Systems (NASDAQ:KRMD)+10%; today announcedFDA510(k) clearance that expands on-label use of the FREEDOM60 Infusion System to two additional subcutaneous Ig (SCIg) medications, Cutaquig®, manufactured by Octapharma, and Xembify®, manufactured by Grifols.\nCalamp Corp. (NASDAQ:CAMP)-14.9%; reported Q3 EPS of ($0.08), $0.16 worse than the analyst estimate of $0.08. Revenue for the quarter came in at $69 million versus the consensus estimate of $79.18 million.\nBlackBerry (NYSE:BB) -1.6%;reported Q3 EPS $0.00 vs $(0.07) Estimate,Sales $184.00M Beat $177.25M Estimate.","news_type":1,"symbols_score_info":{"ACST":0.9,"BB":0.9,"CAMP":0.9,"KRMD":0.9,"VOYA":0.9}},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"},{"id":691336702,"gmtCreate":1640135132114,"gmtModify":1640135132480,"author":{"id":"3586490638953193","authorId":"3586490638953193","name":"Jess261","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":3,"crmLevelSwitch":0,"authorIdStr":"3586490638953193","idStr":"3586490638953193"},"htmlText":"Okay&nbsp;","listText":"Okay&nbsp;","text":"Okay","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/691336702","repostId":1111567016,"repostType":4,"repost":{"id":"1111567016","kind":"news","pubTimestamp":1640133346,"share":"https://ttm.financial/m/news/1111567016?lang=&edition=full","pubTime":"2021-12-22 08:35","market":"us","language":"en","title":"After-Hours Stock Movers: Acasti Pharma,Calamp,BlackBerry and more","url":"https://stock-news.laohu8.com/highlight/detail?id=1111567016","media":"StreetInsider","summary":"After-Hours Stock Movers:\nAcasti Pharma (NASDAQ:ACST)+30%; Oppenheimer initiates coverage on Acasti ","content":"<p>After-Hours Stock Movers:</p>\n<p>Acasti Pharma (NASDAQ:ACST)<b>+30%</b>; Oppenheimer initiates coverage on Acasti Pharma (NASDAQ:ACST) with a Outperform rating and a price target of $6.00.</p>\n<p>Voya Financial (NYSE:VOYA)<b>+8%</b>; will replace CoreSite Realty Corp. (NYSE:COR) in theS&amp;PMidCap 400 effective prior to the opening of trading on Tuesday, December 28. S&amp;P 500 / 100 constituent American Tower Corp. (NYSE:AMT) is acquiring CoreSite Realty in a deal expected to be completed soon pending final closing conditions.</p>\n<p>Repro Med Systems (NASDAQ:KRMD)<b>+10%</b>; today announcedFDA510(k) clearance that expands on-label use of the FREEDOM60 Infusion System to two additional subcutaneous Ig (SCIg) medications, Cutaquig®, manufactured by Octapharma, and Xembify®, manufactured by Grifols.</p>\n<p>Calamp Corp. (NASDAQ:CAMP)<b>-14.9%</b>; reported Q3 EPS of ($0.08), $0.16 worse than the analyst estimate of $0.08. Revenue for the quarter came in at $69 million versus the consensus estimate of $79.18 million.</p>\n<p>BlackBerry&nbsp;(NYSE:BB)&nbsp;-1.6%;reported&nbsp;Q3 EPS $0.00 vs $(0.07) Estimate,Sales $184.00M Beat $177.25M Estimate.</p>","source":"highlight_streetinsider","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>After-Hours Stock Movers: Acasti Pharma,Calamp,BlackBerry and more</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAfter-Hours Stock Movers: Acasti Pharma,Calamp,BlackBerry and more\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-22 08:35 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.streetinsider.com/Special+Reports/After-Hours+Stock+Movers+1221%3A+%28ACST%29+%28VOYA%29+%28KRMD%29+Higher%2C+%28CAMP%29+Lower/19381258.html><strong>StreetInsider</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>After-Hours Stock Movers:\nAcasti Pharma (NASDAQ:ACST)+30%; Oppenheimer initiates coverage on Acasti Pharma (NASDAQ:ACST) with a Outperform rating and a price target of $6.00.\nVoya Financial (NYSE:VOYA...</p>\n\n<a href=\"https://www.streetinsider.com/Special+Reports/After-Hours+Stock+Movers+1221%3A+%28ACST%29+%28VOYA%29+%28KRMD%29+Higher%2C+%28CAMP%29+Lower/19381258.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"VOYA":"Voya Financial, Inc.","BB":"黑莓","CAMP":"Camp4 Therapeutics Corp.","KRMD":"Repro Med Systems, Inc."},"source_url":"https://www.streetinsider.com/Special+Reports/After-Hours+Stock+Movers+1221%3A+%28ACST%29+%28VOYA%29+%28KRMD%29+Higher%2C+%28CAMP%29+Lower/19381258.html","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1111567016","content_text":"After-Hours Stock Movers:\nAcasti Pharma (NASDAQ:ACST)+30%; Oppenheimer initiates coverage on Acasti Pharma (NASDAQ:ACST) with a Outperform rating and a price target of $6.00.\nVoya Financial (NYSE:VOYA)+8%; will replace CoreSite Realty Corp. (NYSE:COR) in theS&PMidCap 400 effective prior to the opening of trading on Tuesday, December 28. S&P 500 / 100 constituent American Tower Corp. (NYSE:AMT) is acquiring CoreSite Realty in a deal expected to be completed soon pending final closing conditions.\nRepro Med Systems (NASDAQ:KRMD)+10%; today announcedFDA510(k) clearance that expands on-label use of the FREEDOM60 Infusion System to two additional subcutaneous Ig (SCIg) medications, Cutaquig®, manufactured by Octapharma, and Xembify®, manufactured by Grifols.\nCalamp Corp. (NASDAQ:CAMP)-14.9%; reported Q3 EPS of ($0.08), $0.16 worse than the analyst estimate of $0.08. Revenue for the quarter came in at $69 million versus the consensus estimate of $79.18 million.\nBlackBerry (NYSE:BB) -1.6%;reported Q3 EPS $0.00 vs $(0.07) Estimate,Sales $184.00M Beat $177.25M Estimate.","news_type":1,"symbols_score_info":{"ACST":0.9,"BB":0.9,"CAMP":0.9,"KRMD":0.9,"VOYA":0.9}},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"},{"id":691331239,"gmtCreate":1640134915552,"gmtModify":1640134915660,"author":{"id":"3582621321537409","authorId":"3582621321537409","name":"BCbcbc","avatar":"https://static.tigerbbs.com/a2ddf6e8e0f63a046421fe1babb27e2f","vip":1,"crmLevel":7,"crmLevelSwitch":0,"authorIdStr":"3582621321537409","idStr":"3582621321537409"},"htmlText":"Nice","listText":"Nice","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/691331239","repostId":1111567016,"repostType":2,"repost":{"id":"1111567016","kind":"news","pubTimestamp":1640133346,"share":"https://ttm.financial/m/news/1111567016?lang=&edition=full","pubTime":"2021-12-22 08:35","market":"us","language":"en","title":"After-Hours Stock Movers: Acasti Pharma,Calamp,BlackBerry and more","url":"https://stock-news.laohu8.com/highlight/detail?id=1111567016","media":"StreetInsider","summary":"After-Hours Stock Movers:\nAcasti Pharma (NASDAQ:ACST)+30%; Oppenheimer initiates coverage on Acasti ","content":"<p>After-Hours Stock Movers:</p>\n<p>Acasti Pharma (NASDAQ:ACST)<b>+30%</b>; Oppenheimer initiates coverage on Acasti Pharma (NASDAQ:ACST) with a Outperform rating and a price target of $6.00.</p>\n<p>Voya Financial (NYSE:VOYA)<b>+8%</b>; will replace CoreSite Realty Corp. (NYSE:COR) in theS&amp;PMidCap 400 effective prior to the opening of trading on Tuesday, December 28. S&amp;P 500 / 100 constituent American Tower Corp. (NYSE:AMT) is acquiring CoreSite Realty in a deal expected to be completed soon pending final closing conditions.</p>\n<p>Repro Med Systems (NASDAQ:KRMD)<b>+10%</b>; today announcedFDA510(k) clearance that expands on-label use of the FREEDOM60 Infusion System to two additional subcutaneous Ig (SCIg) medications, Cutaquig®, manufactured by Octapharma, and Xembify®, manufactured by Grifols.</p>\n<p>Calamp Corp. (NASDAQ:CAMP)<b>-14.9%</b>; reported Q3 EPS of ($0.08), $0.16 worse than the analyst estimate of $0.08. Revenue for the quarter came in at $69 million versus the consensus estimate of $79.18 million.</p>\n<p>BlackBerry&nbsp;(NYSE:BB)&nbsp;-1.6%;reported&nbsp;Q3 EPS $0.00 vs $(0.07) Estimate,Sales $184.00M Beat $177.25M Estimate.</p>","source":"highlight_streetinsider","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>After-Hours Stock Movers: Acasti Pharma,Calamp,BlackBerry and more</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAfter-Hours Stock Movers: Acasti Pharma,Calamp,BlackBerry and more\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-22 08:35 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.streetinsider.com/Special+Reports/After-Hours+Stock+Movers+1221%3A+%28ACST%29+%28VOYA%29+%28KRMD%29+Higher%2C+%28CAMP%29+Lower/19381258.html><strong>StreetInsider</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>After-Hours Stock Movers:\nAcasti Pharma (NASDAQ:ACST)+30%; Oppenheimer initiates coverage on Acasti Pharma (NASDAQ:ACST) with a Outperform rating and a price target of $6.00.\nVoya Financial (NYSE:VOYA...</p>\n\n<a href=\"https://www.streetinsider.com/Special+Reports/After-Hours+Stock+Movers+1221%3A+%28ACST%29+%28VOYA%29+%28KRMD%29+Higher%2C+%28CAMP%29+Lower/19381258.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"VOYA":"Voya Financial, Inc.","BB":"黑莓","CAMP":"Camp4 Therapeutics Corp.","KRMD":"Repro Med Systems, Inc."},"source_url":"https://www.streetinsider.com/Special+Reports/After-Hours+Stock+Movers+1221%3A+%28ACST%29+%28VOYA%29+%28KRMD%29+Higher%2C+%28CAMP%29+Lower/19381258.html","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1111567016","content_text":"After-Hours Stock Movers:\nAcasti Pharma (NASDAQ:ACST)+30%; Oppenheimer initiates coverage on Acasti Pharma (NASDAQ:ACST) with a Outperform rating and a price target of $6.00.\nVoya Financial (NYSE:VOYA)+8%; will replace CoreSite Realty Corp. (NYSE:COR) in theS&PMidCap 400 effective prior to the opening of trading on Tuesday, December 28. S&P 500 / 100 constituent American Tower Corp. (NYSE:AMT) is acquiring CoreSite Realty in a deal expected to be completed soon pending final closing conditions.\nRepro Med Systems (NASDAQ:KRMD)+10%; today announcedFDA510(k) clearance that expands on-label use of the FREEDOM60 Infusion System to two additional subcutaneous Ig (SCIg) medications, Cutaquig®, manufactured by Octapharma, and Xembify®, manufactured by Grifols.\nCalamp Corp. (NASDAQ:CAMP)-14.9%; reported Q3 EPS of ($0.08), $0.16 worse than the analyst estimate of $0.08. Revenue for the quarter came in at $69 million versus the consensus estimate of $79.18 million.\nBlackBerry (NYSE:BB) -1.6%;reported Q3 EPS $0.00 vs $(0.07) Estimate,Sales $184.00M Beat $177.25M Estimate.","news_type":1,"symbols_score_info":{"ACST":0.9,"BB":0.9,"CAMP":0.9,"KRMD":0.9,"VOYA":0.9}},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"},{"id":691331924,"gmtCreate":1640134856987,"gmtModify":1640134857799,"author":{"id":"3557629001242050","authorId":"3557629001242050","name":"kksuen","avatar":"https://static.tigerbbs.com/e1eb0ceb998a78cefb82c2f66d2addb1","vip":1,"crmLevel":5,"crmLevelSwitch":0,"authorIdStr":"3557629001242050","idStr":"3557629001242050"},"htmlText":"Like pls","listText":"Like pls","text":"Like pls","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/691331924","repostId":1111567016,"repostType":4,"repost":{"id":"1111567016","kind":"news","pubTimestamp":1640133346,"share":"https://ttm.financial/m/news/1111567016?lang=&edition=full","pubTime":"2021-12-22 08:35","market":"us","language":"en","title":"After-Hours Stock Movers: Acasti Pharma,Calamp,BlackBerry and more","url":"https://stock-news.laohu8.com/highlight/detail?id=1111567016","media":"StreetInsider","summary":"After-Hours Stock Movers:\nAcasti Pharma (NASDAQ:ACST)+30%; Oppenheimer initiates coverage on Acasti ","content":"<p>After-Hours Stock Movers:</p>\n<p>Acasti Pharma (NASDAQ:ACST)<b>+30%</b>; Oppenheimer initiates coverage on Acasti Pharma (NASDAQ:ACST) with a Outperform rating and a price target of $6.00.</p>\n<p>Voya Financial (NYSE:VOYA)<b>+8%</b>; will replace CoreSite Realty Corp. (NYSE:COR) in theS&amp;PMidCap 400 effective prior to the opening of trading on Tuesday, December 28. S&amp;P 500 / 100 constituent American Tower Corp. (NYSE:AMT) is acquiring CoreSite Realty in a deal expected to be completed soon pending final closing conditions.</p>\n<p>Repro Med Systems (NASDAQ:KRMD)<b>+10%</b>; today announcedFDA510(k) clearance that expands on-label use of the FREEDOM60 Infusion System to two additional subcutaneous Ig (SCIg) medications, Cutaquig®, manufactured by Octapharma, and Xembify®, manufactured by Grifols.</p>\n<p>Calamp Corp. (NASDAQ:CAMP)<b>-14.9%</b>; reported Q3 EPS of ($0.08), $0.16 worse than the analyst estimate of $0.08. Revenue for the quarter came in at $69 million versus the consensus estimate of $79.18 million.</p>\n<p>BlackBerry&nbsp;(NYSE:BB)&nbsp;-1.6%;reported&nbsp;Q3 EPS $0.00 vs $(0.07) Estimate,Sales $184.00M Beat $177.25M Estimate.</p>","source":"highlight_streetinsider","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>After-Hours Stock Movers: Acasti Pharma,Calamp,BlackBerry and more</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAfter-Hours Stock Movers: Acasti Pharma,Calamp,BlackBerry and more\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-22 08:35 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.streetinsider.com/Special+Reports/After-Hours+Stock+Movers+1221%3A+%28ACST%29+%28VOYA%29+%28KRMD%29+Higher%2C+%28CAMP%29+Lower/19381258.html><strong>StreetInsider</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>After-Hours Stock Movers:\nAcasti Pharma (NASDAQ:ACST)+30%; Oppenheimer initiates coverage on Acasti Pharma (NASDAQ:ACST) with a Outperform rating and a price target of $6.00.\nVoya Financial (NYSE:VOYA...</p>\n\n<a href=\"https://www.streetinsider.com/Special+Reports/After-Hours+Stock+Movers+1221%3A+%28ACST%29+%28VOYA%29+%28KRMD%29+Higher%2C+%28CAMP%29+Lower/19381258.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"VOYA":"Voya Financial, Inc.","BB":"黑莓","CAMP":"Camp4 Therapeutics Corp.","KRMD":"Repro Med Systems, Inc."},"source_url":"https://www.streetinsider.com/Special+Reports/After-Hours+Stock+Movers+1221%3A+%28ACST%29+%28VOYA%29+%28KRMD%29+Higher%2C+%28CAMP%29+Lower/19381258.html","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1111567016","content_text":"After-Hours Stock Movers:\nAcasti Pharma (NASDAQ:ACST)+30%; Oppenheimer initiates coverage on Acasti Pharma (NASDAQ:ACST) with a Outperform rating and a price target of $6.00.\nVoya Financial (NYSE:VOYA)+8%; will replace CoreSite Realty Corp. (NYSE:COR) in theS&PMidCap 400 effective prior to the opening of trading on Tuesday, December 28. S&P 500 / 100 constituent American Tower Corp. (NYSE:AMT) is acquiring CoreSite Realty in a deal expected to be completed soon pending final closing conditions.\nRepro Med Systems (NASDAQ:KRMD)+10%; today announcedFDA510(k) clearance that expands on-label use of the FREEDOM60 Infusion System to two additional subcutaneous Ig (SCIg) medications, Cutaquig®, manufactured by Octapharma, and Xembify®, manufactured by Grifols.\nCalamp Corp. (NASDAQ:CAMP)-14.9%; reported Q3 EPS of ($0.08), $0.16 worse than the analyst estimate of $0.08. Revenue for the quarter came in at $69 million versus the consensus estimate of $79.18 million.\nBlackBerry (NYSE:BB) -1.6%;reported Q3 EPS $0.00 vs $(0.07) Estimate,Sales $184.00M Beat $177.25M Estimate.","news_type":1,"symbols_score_info":{"ACST":0.9,"BB":0.9,"CAMP":0.9,"KRMD":0.9,"VOYA":0.9}},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":7072116,"gmtCreate":1640134908076,"gmtModify":1640134908182,"authorId":3583188574218530,"author":{"id":3583188574218530,"idStr":"3583188574218530","authorId":3583188574218530,"name":"kaite","avatar":"https://static.tigerbbs.com/40a7ccc0fdb94090d52b243148991f8a","vip":1,"crmLevel":5,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":691331924,"type":1,"supId":0,"prevId":0,"content":"<u>ok</u>","text":"<u>ok</u>","html":"<u>ok</u>"},{"id":7072109,"gmtCreate":1640134864188,"gmtModify":1640134864280,"authorId":3570509119176291,"author":{"id":3570509119176291,"idStr":"3570509119176291","authorId":3570509119176291,"name":"Zenkyn","avatar":"https://static.tigerbbs.com/192b5b1521b264f31a2685e7170d3cde","vip":1,"crmLevel":3,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":691331924,"type":1,"supId":0,"prevId":0,"content":"<u>ok</u>","text":"<u>ok</u>","html":"<u>ok</u>"}],"langContent":"CN"},{"id":691331039,"gmtCreate":1640134856924,"gmtModify":1640134857267,"author":{"id":"3570509119176291","authorId":"3570509119176291","name":"Zenkyn","avatar":"https://static.tigerbbs.com/192b5b1521b264f31a2685e7170d3cde","vip":1,"crmLevel":3,"crmLevelSwitch":0,"authorIdStr":"3570509119176291","idStr":"3570509119176291"},"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/691331039","repostId":1111567016,"repostType":4,"repost":{"id":"1111567016","kind":"news","pubTimestamp":1640133346,"share":"https://ttm.financial/m/news/1111567016?lang=&edition=full","pubTime":"2021-12-22 08:35","market":"us","language":"en","title":"After-Hours Stock Movers: Acasti Pharma,Calamp,BlackBerry and more","url":"https://stock-news.laohu8.com/highlight/detail?id=1111567016","media":"StreetInsider","summary":"After-Hours Stock Movers:\nAcasti Pharma (NASDAQ:ACST)+30%; Oppenheimer initiates coverage on Acasti ","content":"<p>After-Hours Stock Movers:</p>\n<p>Acasti Pharma (NASDAQ:ACST)<b>+30%</b>; Oppenheimer initiates coverage on Acasti Pharma (NASDAQ:ACST) with a Outperform rating and a price target of $6.00.</p>\n<p>Voya Financial (NYSE:VOYA)<b>+8%</b>; will replace CoreSite Realty Corp. (NYSE:COR) in theS&amp;PMidCap 400 effective prior to the opening of trading on Tuesday, December 28. S&amp;P 500 / 100 constituent American Tower Corp. (NYSE:AMT) is acquiring CoreSite Realty in a deal expected to be completed soon pending final closing conditions.</p>\n<p>Repro Med Systems (NASDAQ:KRMD)<b>+10%</b>; today announcedFDA510(k) clearance that expands on-label use of the FREEDOM60 Infusion System to two additional subcutaneous Ig (SCIg) medications, Cutaquig®, manufactured by Octapharma, and Xembify®, manufactured by Grifols.</p>\n<p>Calamp Corp. (NASDAQ:CAMP)<b>-14.9%</b>; reported Q3 EPS of ($0.08), $0.16 worse than the analyst estimate of $0.08. Revenue for the quarter came in at $69 million versus the consensus estimate of $79.18 million.</p>\n<p>BlackBerry&nbsp;(NYSE:BB)&nbsp;-1.6%;reported&nbsp;Q3 EPS $0.00 vs $(0.07) Estimate,Sales $184.00M Beat $177.25M Estimate.</p>","source":"highlight_streetinsider","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>After-Hours Stock Movers: Acasti Pharma,Calamp,BlackBerry and more</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAfter-Hours Stock Movers: Acasti Pharma,Calamp,BlackBerry and more\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-22 08:35 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.streetinsider.com/Special+Reports/After-Hours+Stock+Movers+1221%3A+%28ACST%29+%28VOYA%29+%28KRMD%29+Higher%2C+%28CAMP%29+Lower/19381258.html><strong>StreetInsider</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>After-Hours Stock Movers:\nAcasti Pharma (NASDAQ:ACST)+30%; Oppenheimer initiates coverage on Acasti Pharma (NASDAQ:ACST) with a Outperform rating and a price target of $6.00.\nVoya Financial (NYSE:VOYA...</p>\n\n<a href=\"https://www.streetinsider.com/Special+Reports/After-Hours+Stock+Movers+1221%3A+%28ACST%29+%28VOYA%29+%28KRMD%29+Higher%2C+%28CAMP%29+Lower/19381258.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"VOYA":"Voya Financial, Inc.","BB":"黑莓","CAMP":"Camp4 Therapeutics Corp.","KRMD":"Repro Med Systems, Inc."},"source_url":"https://www.streetinsider.com/Special+Reports/After-Hours+Stock+Movers+1221%3A+%28ACST%29+%28VOYA%29+%28KRMD%29+Higher%2C+%28CAMP%29+Lower/19381258.html","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1111567016","content_text":"After-Hours Stock Movers:\nAcasti Pharma (NASDAQ:ACST)+30%; Oppenheimer initiates coverage on Acasti Pharma (NASDAQ:ACST) with a Outperform rating and a price target of $6.00.\nVoya Financial (NYSE:VOYA)+8%; will replace CoreSite Realty Corp. (NYSE:COR) in theS&PMidCap 400 effective prior to the opening of trading on Tuesday, December 28. S&P 500 / 100 constituent American Tower Corp. (NYSE:AMT) is acquiring CoreSite Realty in a deal expected to be completed soon pending final closing conditions.\nRepro Med Systems (NASDAQ:KRMD)+10%; today announcedFDA510(k) clearance that expands on-label use of the FREEDOM60 Infusion System to two additional subcutaneous Ig (SCIg) medications, Cutaquig®, manufactured by Octapharma, and Xembify®, manufactured by Grifols.\nCalamp Corp. (NASDAQ:CAMP)-14.9%; reported Q3 EPS of ($0.08), $0.16 worse than the analyst estimate of $0.08. Revenue for the quarter came in at $69 million versus the consensus estimate of $79.18 million.\nBlackBerry (NYSE:BB) -1.6%;reported Q3 EPS $0.00 vs $(0.07) Estimate,Sales $184.00M Beat $177.25M Estimate.","news_type":1,"symbols_score_info":{"ACST":0.9,"BB":0.9,"CAMP":0.9,"KRMD":0.9,"VOYA":0.9}},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":7072108,"gmtCreate":1640134863071,"gmtModify":1640134863105,"authorId":3557629001242050,"author":{"id":3557629001242050,"idStr":"3557629001242050","authorId":3557629001242050,"name":"kksuen","avatar":"https://static.tigerbbs.com/e1eb0ceb998a78cefb82c2f66d2addb1","vip":1,"crmLevel":5,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":691331039,"type":1,"supId":0,"prevId":0,"content":"<u>ok</u>","text":"<u>ok</u>","html":"<u>ok</u>"}],"langContent":"CN"},{"id":691333584,"gmtCreate":1640134829864,"gmtModify":1640134830057,"author":{"id":"3582848285382110","authorId":"3582848285382110","name":"justforcoins","avatar":"https://static.tigerbbs.com/cc434d8eefab9556c9a75a287e8eaa1d","vip":1,"crmLevel":6,"crmLevelSwitch":0,"authorIdStr":"3582848285382110","idStr":"3582848285382110"},"htmlText":"K","listText":"K","text":"K","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/691333584","repostId":1111567016,"repostType":4,"repost":{"id":"1111567016","kind":"news","pubTimestamp":1640133346,"share":"https://ttm.financial/m/news/1111567016?lang=&edition=full","pubTime":"2021-12-22 08:35","market":"us","language":"en","title":"After-Hours Stock Movers: Acasti Pharma,Calamp,BlackBerry and more","url":"https://stock-news.laohu8.com/highlight/detail?id=1111567016","media":"StreetInsider","summary":"After-Hours Stock Movers:\nAcasti Pharma (NASDAQ:ACST)+30%; Oppenheimer initiates coverage on Acasti ","content":"<p>After-Hours Stock Movers:</p>\n<p>Acasti Pharma (NASDAQ:ACST)<b>+30%</b>; Oppenheimer initiates coverage on Acasti Pharma (NASDAQ:ACST) with a Outperform rating and a price target of $6.00.</p>\n<p>Voya Financial (NYSE:VOYA)<b>+8%</b>; will replace CoreSite Realty Corp. (NYSE:COR) in theS&amp;PMidCap 400 effective prior to the opening of trading on Tuesday, December 28. S&amp;P 500 / 100 constituent American Tower Corp. (NYSE:AMT) is acquiring CoreSite Realty in a deal expected to be completed soon pending final closing conditions.</p>\n<p>Repro Med Systems (NASDAQ:KRMD)<b>+10%</b>; today announcedFDA510(k) clearance that expands on-label use of the FREEDOM60 Infusion System to two additional subcutaneous Ig (SCIg) medications, Cutaquig®, manufactured by Octapharma, and Xembify®, manufactured by Grifols.</p>\n<p>Calamp Corp. (NASDAQ:CAMP)<b>-14.9%</b>; reported Q3 EPS of ($0.08), $0.16 worse than the analyst estimate of $0.08. Revenue for the quarter came in at $69 million versus the consensus estimate of $79.18 million.</p>\n<p>BlackBerry&nbsp;(NYSE:BB)&nbsp;-1.6%;reported&nbsp;Q3 EPS $0.00 vs $(0.07) Estimate,Sales $184.00M Beat $177.25M Estimate.</p>","source":"highlight_streetinsider","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>After-Hours Stock Movers: Acasti Pharma,Calamp,BlackBerry and more</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAfter-Hours Stock Movers: Acasti Pharma,Calamp,BlackBerry and more\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-22 08:35 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.streetinsider.com/Special+Reports/After-Hours+Stock+Movers+1221%3A+%28ACST%29+%28VOYA%29+%28KRMD%29+Higher%2C+%28CAMP%29+Lower/19381258.html><strong>StreetInsider</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>After-Hours Stock Movers:\nAcasti Pharma (NASDAQ:ACST)+30%; Oppenheimer initiates coverage on Acasti Pharma (NASDAQ:ACST) with a Outperform rating and a price target of $6.00.\nVoya Financial (NYSE:VOYA...</p>\n\n<a href=\"https://www.streetinsider.com/Special+Reports/After-Hours+Stock+Movers+1221%3A+%28ACST%29+%28VOYA%29+%28KRMD%29+Higher%2C+%28CAMP%29+Lower/19381258.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"VOYA":"Voya Financial, Inc.","BB":"黑莓","CAMP":"Camp4 Therapeutics Corp.","KRMD":"Repro Med Systems, Inc."},"source_url":"https://www.streetinsider.com/Special+Reports/After-Hours+Stock+Movers+1221%3A+%28ACST%29+%28VOYA%29+%28KRMD%29+Higher%2C+%28CAMP%29+Lower/19381258.html","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1111567016","content_text":"After-Hours Stock Movers:\nAcasti Pharma (NASDAQ:ACST)+30%; Oppenheimer initiates coverage on Acasti Pharma (NASDAQ:ACST) with a Outperform rating and a price target of $6.00.\nVoya Financial (NYSE:VOYA)+8%; will replace CoreSite Realty Corp. (NYSE:COR) in theS&PMidCap 400 effective prior to the opening of trading on Tuesday, December 28. S&P 500 / 100 constituent American Tower Corp. (NYSE:AMT) is acquiring CoreSite Realty in a deal expected to be completed soon pending final closing conditions.\nRepro Med Systems (NASDAQ:KRMD)+10%; today announcedFDA510(k) clearance that expands on-label use of the FREEDOM60 Infusion System to two additional subcutaneous Ig (SCIg) medications, Cutaquig®, manufactured by Octapharma, and Xembify®, manufactured by Grifols.\nCalamp Corp. (NASDAQ:CAMP)-14.9%; reported Q3 EPS of ($0.08), $0.16 worse than the analyst estimate of $0.08. Revenue for the quarter came in at $69 million versus the consensus estimate of $79.18 million.\nBlackBerry (NYSE:BB) -1.6%;reported Q3 EPS $0.00 vs $(0.07) Estimate,Sales $184.00M Beat $177.25M Estimate.","news_type":1,"symbols_score_info":{"ACST":0.9,"BB":0.9,"CAMP":0.9,"KRMD":0.9,"VOYA":0.9}},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"},{"id":691333192,"gmtCreate":1640134748122,"gmtModify":1640134748360,"author":{"id":"3585607107146910","authorId":"3585607107146910","name":"10f6ccb4","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","vip":1,"crmLevel":1,"crmLevelSwitch":0,"authorIdStr":"3585607107146910","idStr":"3585607107146910"},"htmlText":"[smile]&nbsp;","listText":"[smile]&nbsp;","text":"[smile]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/691333192","repostId":1111567016,"repostType":4,"repost":{"id":"1111567016","kind":"news","pubTimestamp":1640133346,"share":"https://ttm.financial/m/news/1111567016?lang=&edition=full","pubTime":"2021-12-22 08:35","market":"us","language":"en","title":"After-Hours Stock Movers: Acasti Pharma,Calamp,BlackBerry and more","url":"https://stock-news.laohu8.com/highlight/detail?id=1111567016","media":"StreetInsider","summary":"After-Hours Stock Movers:\nAcasti Pharma (NASDAQ:ACST)+30%; Oppenheimer initiates coverage on Acasti ","content":"<p>After-Hours Stock Movers:</p>\n<p>Acasti Pharma (NASDAQ:ACST)<b>+30%</b>; Oppenheimer initiates coverage on Acasti Pharma (NASDAQ:ACST) with a Outperform rating and a price target of $6.00.</p>\n<p>Voya Financial (NYSE:VOYA)<b>+8%</b>; will replace CoreSite Realty Corp. (NYSE:COR) in theS&amp;PMidCap 400 effective prior to the opening of trading on Tuesday, December 28. S&amp;P 500 / 100 constituent American Tower Corp. (NYSE:AMT) is acquiring CoreSite Realty in a deal expected to be completed soon pending final closing conditions.</p>\n<p>Repro Med Systems (NASDAQ:KRMD)<b>+10%</b>; today announcedFDA510(k) clearance that expands on-label use of the FREEDOM60 Infusion System to two additional subcutaneous Ig (SCIg) medications, Cutaquig®, manufactured by Octapharma, and Xembify®, manufactured by Grifols.</p>\n<p>Calamp Corp. (NASDAQ:CAMP)<b>-14.9%</b>; reported Q3 EPS of ($0.08), $0.16 worse than the analyst estimate of $0.08. Revenue for the quarter came in at $69 million versus the consensus estimate of $79.18 million.</p>\n<p>BlackBerry&nbsp;(NYSE:BB)&nbsp;-1.6%;reported&nbsp;Q3 EPS $0.00 vs $(0.07) Estimate,Sales $184.00M Beat $177.25M Estimate.</p>","source":"highlight_streetinsider","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>After-Hours Stock Movers: Acasti Pharma,Calamp,BlackBerry and more</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAfter-Hours Stock Movers: Acasti Pharma,Calamp,BlackBerry and more\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-22 08:35 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.streetinsider.com/Special+Reports/After-Hours+Stock+Movers+1221%3A+%28ACST%29+%28VOYA%29+%28KRMD%29+Higher%2C+%28CAMP%29+Lower/19381258.html><strong>StreetInsider</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>After-Hours Stock Movers:\nAcasti Pharma (NASDAQ:ACST)+30%; Oppenheimer initiates coverage on Acasti Pharma (NASDAQ:ACST) with a Outperform rating and a price target of $6.00.\nVoya Financial (NYSE:VOYA...</p>\n\n<a href=\"https://www.streetinsider.com/Special+Reports/After-Hours+Stock+Movers+1221%3A+%28ACST%29+%28VOYA%29+%28KRMD%29+Higher%2C+%28CAMP%29+Lower/19381258.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"VOYA":"Voya Financial, Inc.","BB":"黑莓","CAMP":"Camp4 Therapeutics Corp.","KRMD":"Repro Med Systems, Inc."},"source_url":"https://www.streetinsider.com/Special+Reports/After-Hours+Stock+Movers+1221%3A+%28ACST%29+%28VOYA%29+%28KRMD%29+Higher%2C+%28CAMP%29+Lower/19381258.html","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1111567016","content_text":"After-Hours Stock Movers:\nAcasti Pharma (NASDAQ:ACST)+30%; Oppenheimer initiates coverage on Acasti Pharma (NASDAQ:ACST) with a Outperform rating and a price target of $6.00.\nVoya Financial (NYSE:VOYA)+8%; will replace CoreSite Realty Corp. (NYSE:COR) in theS&PMidCap 400 effective prior to the opening of trading on Tuesday, December 28. S&P 500 / 100 constituent American Tower Corp. (NYSE:AMT) is acquiring CoreSite Realty in a deal expected to be completed soon pending final closing conditions.\nRepro Med Systems (NASDAQ:KRMD)+10%; today announcedFDA510(k) clearance that expands on-label use of the FREEDOM60 Infusion System to two additional subcutaneous Ig (SCIg) medications, Cutaquig®, manufactured by Octapharma, and Xembify®, manufactured by Grifols.\nCalamp Corp. (NASDAQ:CAMP)-14.9%; reported Q3 EPS of ($0.08), $0.16 worse than the analyst estimate of $0.08. Revenue for the quarter came in at $69 million versus the consensus estimate of $79.18 million.\nBlackBerry (NYSE:BB) -1.6%;reported Q3 EPS $0.00 vs $(0.07) Estimate,Sales $184.00M Beat $177.25M Estimate.","news_type":1,"symbols_score_info":{"ACST":0.9,"BB":0.9,"CAMP":0.9,"KRMD":0.9,"VOYA":0.9}},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":7072104,"gmtCreate":1640134836799,"gmtModify":1640134836891,"authorId":3582848285382110,"author":{"id":3582848285382110,"idStr":"3582848285382110","authorId":3582848285382110,"name":"justforcoins","avatar":"https://static.tigerbbs.com/cc434d8eefab9556c9a75a287e8eaa1d","vip":1,"crmLevel":6,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":691333192,"type":1,"supId":0,"prevId":0,"content":"<u>k</u>","text":"<u>k</u>","html":"<u>k</u>"}],"langContent":"CN"},{"id":691339780,"gmtCreate":1640134685862,"gmtModify":1640134686089,"author":{"id":"3570089742250981","authorId":"3570089742250981","name":"hyhop","avatar":"https://static.tigerbbs.com/0c810c839e0549461f5f465b72f9be83","vip":1,"crmLevel":3,"crmLevelSwitch":0,"authorIdStr":"3570089742250981","idStr":"3570089742250981"},"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/691339780","repostId":1111567016,"repostType":4,"repost":{"id":"1111567016","kind":"news","pubTimestamp":1640133346,"share":"https://ttm.financial/m/news/1111567016?lang=&edition=full","pubTime":"2021-12-22 08:35","market":"us","language":"en","title":"After-Hours Stock Movers: Acasti Pharma,Calamp,BlackBerry and more","url":"https://stock-news.laohu8.com/highlight/detail?id=1111567016","media":"StreetInsider","summary":"After-Hours Stock Movers:\nAcasti Pharma (NASDAQ:ACST)+30%; Oppenheimer initiates coverage on Acasti ","content":"<p>After-Hours Stock Movers:</p>\n<p>Acasti Pharma (NASDAQ:ACST)<b>+30%</b>; Oppenheimer initiates coverage on Acasti Pharma (NASDAQ:ACST) with a Outperform rating and a price target of $6.00.</p>\n<p>Voya Financial (NYSE:VOYA)<b>+8%</b>; will replace CoreSite Realty Corp. (NYSE:COR) in theS&amp;PMidCap 400 effective prior to the opening of trading on Tuesday, December 28. S&amp;P 500 / 100 constituent American Tower Corp. (NYSE:AMT) is acquiring CoreSite Realty in a deal expected to be completed soon pending final closing conditions.</p>\n<p>Repro Med Systems (NASDAQ:KRMD)<b>+10%</b>; today announcedFDA510(k) clearance that expands on-label use of the FREEDOM60 Infusion System to two additional subcutaneous Ig (SCIg) medications, Cutaquig®, manufactured by Octapharma, and Xembify®, manufactured by Grifols.</p>\n<p>Calamp Corp. (NASDAQ:CAMP)<b>-14.9%</b>; reported Q3 EPS of ($0.08), $0.16 worse than the analyst estimate of $0.08. Revenue for the quarter came in at $69 million versus the consensus estimate of $79.18 million.</p>\n<p>BlackBerry&nbsp;(NYSE:BB)&nbsp;-1.6%;reported&nbsp;Q3 EPS $0.00 vs $(0.07) Estimate,Sales $184.00M Beat $177.25M Estimate.</p>","source":"highlight_streetinsider","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>After-Hours Stock Movers: Acasti Pharma,Calamp,BlackBerry and more</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAfter-Hours Stock Movers: Acasti Pharma,Calamp,BlackBerry and more\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-22 08:35 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.streetinsider.com/Special+Reports/After-Hours+Stock+Movers+1221%3A+%28ACST%29+%28VOYA%29+%28KRMD%29+Higher%2C+%28CAMP%29+Lower/19381258.html><strong>StreetInsider</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>After-Hours Stock Movers:\nAcasti Pharma (NASDAQ:ACST)+30%; Oppenheimer initiates coverage on Acasti Pharma (NASDAQ:ACST) with a Outperform rating and a price target of $6.00.\nVoya Financial (NYSE:VOYA...</p>\n\n<a href=\"https://www.streetinsider.com/Special+Reports/After-Hours+Stock+Movers+1221%3A+%28ACST%29+%28VOYA%29+%28KRMD%29+Higher%2C+%28CAMP%29+Lower/19381258.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"VOYA":"Voya Financial, Inc.","BB":"黑莓","CAMP":"Camp4 Therapeutics Corp.","KRMD":"Repro Med Systems, Inc."},"source_url":"https://www.streetinsider.com/Special+Reports/After-Hours+Stock+Movers+1221%3A+%28ACST%29+%28VOYA%29+%28KRMD%29+Higher%2C+%28CAMP%29+Lower/19381258.html","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1111567016","content_text":"After-Hours Stock Movers:\nAcasti Pharma (NASDAQ:ACST)+30%; Oppenheimer initiates coverage on Acasti Pharma (NASDAQ:ACST) with a Outperform rating and a price target of $6.00.\nVoya Financial (NYSE:VOYA)+8%; will replace CoreSite Realty Corp. (NYSE:COR) in theS&PMidCap 400 effective prior to the opening of trading on Tuesday, December 28. S&P 500 / 100 constituent American Tower Corp. (NYSE:AMT) is acquiring CoreSite Realty in a deal expected to be completed soon pending final closing conditions.\nRepro Med Systems (NASDAQ:KRMD)+10%; today announcedFDA510(k) clearance that expands on-label use of the FREEDOM60 Infusion System to two additional subcutaneous Ig (SCIg) medications, Cutaquig®, manufactured by Octapharma, and Xembify®, manufactured by Grifols.\nCalamp Corp. (NASDAQ:CAMP)-14.9%; reported Q3 EPS of ($0.08), $0.16 worse than the analyst estimate of $0.08. Revenue for the quarter came in at $69 million versus the consensus estimate of $79.18 million.\nBlackBerry (NYSE:BB) -1.6%;reported Q3 EPS $0.00 vs $(0.07) Estimate,Sales $184.00M Beat $177.25M Estimate.","news_type":1,"symbols_score_info":{"ACST":0.9,"BB":0.9,"CAMP":0.9,"KRMD":0.9,"VOYA":0.9}},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":7072096,"gmtCreate":1640134759593,"gmtModify":1640134759682,"authorId":3585607107146910,"author":{"id":3585607107146910,"idStr":"3585607107146910","authorId":3585607107146910,"name":"10f6ccb4","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","vip":1,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":691339780,"type":1,"supId":0,"prevId":0,"content":"[smile]","text":"[smile]","html":"[smile]"},{"id":7072089,"gmtCreate":1640134690172,"gmtModify":1640134690199,"authorId":3570089742250981,"author":{"id":3570089742250981,"idStr":"3570089742250981","authorId":3570089742250981,"name":"hyhop","avatar":"https://static.tigerbbs.com/0c810c839e0549461f5f465b72f9be83","vip":1,"crmLevel":3,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":691339780,"type":1,"supId":0,"prevId":0,"content":"<u>ok</u>","text":"<u>ok</u>","html":"<u>ok</u>"}],"langContent":"CN"}],"hasMoreComments":true,"newsSizeData":{"likeSize":224,"commentSize":34,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false}}